FDA places CTX001 for SCD on clinical hold

Article Type
Changed
Display Headline
FDA places CTX001 for SCD on clinical hold

Image by Betty Pace
A sickled red blood cell beside a normal one

The US Food and Drug Administration (FDA) has placed a clinical hold on the investigational new drug application (IND) for CTX001. The agent is being developed for the treatment of sickle cell disease (SCD) and β-thalassemia.

The IND was submitted to the FDA in April to support the initiation of a phase 1/2 trial in the US in adult patients with SCD. The hold will be in place pending the resolution of questions as part of the FDA review.

The phase 1/2 trial in Europe in adult patients with transfusion-dependent β-thalassemia is expected to proceed according to schedule. Trial initiation is planned for the second half of 2018.

CTX001 is being co-developed and co-commercialized by CRISPR Therapeutics and Vertex Pharmaceuticals Incorporated.

The agent is an investigational ex vivo CRISPR gene edited therapy for patients with β-thalassemia or sickle cell disease.

The patient’s hematopoietic stem cells are engineered to produce high levels of fetal hemoglobin (HbF; hemoglobin F) in red blood cells.

The increase in HbF levels by CTX001 may potentially alleviate transfusion requirements for β-thalassemia patients and sickle crises for SCD patients. 

Publications
Topics

Image by Betty Pace
A sickled red blood cell beside a normal one

The US Food and Drug Administration (FDA) has placed a clinical hold on the investigational new drug application (IND) for CTX001. The agent is being developed for the treatment of sickle cell disease (SCD) and β-thalassemia.

The IND was submitted to the FDA in April to support the initiation of a phase 1/2 trial in the US in adult patients with SCD. The hold will be in place pending the resolution of questions as part of the FDA review.

The phase 1/2 trial in Europe in adult patients with transfusion-dependent β-thalassemia is expected to proceed according to schedule. Trial initiation is planned for the second half of 2018.

CTX001 is being co-developed and co-commercialized by CRISPR Therapeutics and Vertex Pharmaceuticals Incorporated.

The agent is an investigational ex vivo CRISPR gene edited therapy for patients with β-thalassemia or sickle cell disease.

The patient’s hematopoietic stem cells are engineered to produce high levels of fetal hemoglobin (HbF; hemoglobin F) in red blood cells.

The increase in HbF levels by CTX001 may potentially alleviate transfusion requirements for β-thalassemia patients and sickle crises for SCD patients. 

Image by Betty Pace
A sickled red blood cell beside a normal one

The US Food and Drug Administration (FDA) has placed a clinical hold on the investigational new drug application (IND) for CTX001. The agent is being developed for the treatment of sickle cell disease (SCD) and β-thalassemia.

The IND was submitted to the FDA in April to support the initiation of a phase 1/2 trial in the US in adult patients with SCD. The hold will be in place pending the resolution of questions as part of the FDA review.

The phase 1/2 trial in Europe in adult patients with transfusion-dependent β-thalassemia is expected to proceed according to schedule. Trial initiation is planned for the second half of 2018.

CTX001 is being co-developed and co-commercialized by CRISPR Therapeutics and Vertex Pharmaceuticals Incorporated.

The agent is an investigational ex vivo CRISPR gene edited therapy for patients with β-thalassemia or sickle cell disease.

The patient’s hematopoietic stem cells are engineered to produce high levels of fetal hemoglobin (HbF; hemoglobin F) in red blood cells.

The increase in HbF levels by CTX001 may potentially alleviate transfusion requirements for β-thalassemia patients and sickle crises for SCD patients. 

Publications
Publications
Topics
Article Type
Display Headline
FDA places CTX001 for SCD on clinical hold
Display Headline
FDA places CTX001 for SCD on clinical hold
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica

USPSTF takes another stab at PSA screening recs

Article Type
Changed
Display Headline
USPSTF takes another stab at PSA screening recs

Resources

US Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319:1901-1913.

Carter HB. Prostate-specific antigen (PSA) screening for prostate cancer: revisiting the evidence. JAMA. 2018;319:1866-1868.

US Preventive Services Task Force. Prostate cancer screening final recommendation. Available at: https://screeningforprostatecancer.org/. Accessed May 18, 2018.

US Preventive Services Task Force. Prostate cancer: screening, 2008. Available at:  https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/prostate-cancer-screening-2008. Accessed May 15, 2018.

US Preventive Services Task Force. Prostate cancer: screening. May 2012. Available at: https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/prostate-cancer-screening. Accessed May 15, 2018.

Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a member of the US Community Preventive Services Task Force, a clinical professor at the University of Arizona College of Medicine, and a senior lecturer with the University of Arizona College of Public Health. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflicts of interest relevant to this audiocast.

Issue
The Journal of Family Practice - 67(6)
Publications
Topics
Page Number
audio
Sections
Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a member of the US Community Preventive Services Task Force, a clinical professor at the University of Arizona College of Medicine, and a senior lecturer with the University of Arizona College of Public Health. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflicts of interest relevant to this audiocast.

Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a member of the US Community Preventive Services Task Force, a clinical professor at the University of Arizona College of Medicine, and a senior lecturer with the University of Arizona College of Public Health. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflicts of interest relevant to this audiocast.

Resources

US Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319:1901-1913.

Carter HB. Prostate-specific antigen (PSA) screening for prostate cancer: revisiting the evidence. JAMA. 2018;319:1866-1868.

US Preventive Services Task Force. Prostate cancer screening final recommendation. Available at: https://screeningforprostatecancer.org/. Accessed May 18, 2018.

US Preventive Services Task Force. Prostate cancer: screening, 2008. Available at:  https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/prostate-cancer-screening-2008. Accessed May 15, 2018.

US Preventive Services Task Force. Prostate cancer: screening. May 2012. Available at: https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/prostate-cancer-screening. Accessed May 15, 2018.

Resources

US Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319:1901-1913.

Carter HB. Prostate-specific antigen (PSA) screening for prostate cancer: revisiting the evidence. JAMA. 2018;319:1866-1868.

US Preventive Services Task Force. Prostate cancer screening final recommendation. Available at: https://screeningforprostatecancer.org/. Accessed May 18, 2018.

US Preventive Services Task Force. Prostate cancer: screening, 2008. Available at:  https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/prostate-cancer-screening-2008. Accessed May 15, 2018.

US Preventive Services Task Force. Prostate cancer: screening. May 2012. Available at: https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/prostate-cancer-screening. Accessed May 15, 2018.

Issue
The Journal of Family Practice - 67(6)
Issue
The Journal of Family Practice - 67(6)
Page Number
audio
Page Number
audio
Publications
Publications
Topics
Article Type
Display Headline
USPSTF takes another stab at PSA screening recs
Display Headline
USPSTF takes another stab at PSA screening recs
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Un-Gate On Date
Use ProPublica
CFC Schedule Remove Status
Hide sidebar & use full width
render the right sidebar.

USPSTF offers 3 recommendations for preventing falls in older adults

Article Type
Changed
Display Headline
USPSTF offers 3 recommendations for preventing falls in older adults

Resources

US Preventive Services Task Force. Final recommendation statement: Falls prevention in community-dwelling older adults: interventions. Available at: https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/falls-prevention-in-older-adults-interventions1. Accessed May 8, 2018.

US Preventive Services Task Force. Interventions to prevent falls in community-dwelling older adults. US Preventive Services Task Force recommendation statement. JAMA. 2018;319:1696-1704.

Guirguis-Blake JM, Michael YL, Perdue LA, et al. Interventions to prevent falls in older adults. Updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018;319:1705-1716.

Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a member of the US Community Preventive Services Task Force, a clinical professor at the University of Arizona College of Medicine, and a senior lecturer with the University of Arizona College of Public Health. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflicts of interest relevant to this audiocast.

Issue
The Journal of Family Practice - 67(6)
Publications
Topics
Page Number
audio
Sections
Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a member of the US Community Preventive Services Task Force, a clinical professor at the University of Arizona College of Medicine, and a senior lecturer with the University of Arizona College of Public Health. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflicts of interest relevant to this audiocast.

Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a member of the US Community Preventive Services Task Force, a clinical professor at the University of Arizona College of Medicine, and a senior lecturer with the University of Arizona College of Public Health. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflicts of interest relevant to this audiocast.

Resources

US Preventive Services Task Force. Final recommendation statement: Falls prevention in community-dwelling older adults: interventions. Available at: https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/falls-prevention-in-older-adults-interventions1. Accessed May 8, 2018.

US Preventive Services Task Force. Interventions to prevent falls in community-dwelling older adults. US Preventive Services Task Force recommendation statement. JAMA. 2018;319:1696-1704.

Guirguis-Blake JM, Michael YL, Perdue LA, et al. Interventions to prevent falls in older adults. Updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018;319:1705-1716.

Resources

US Preventive Services Task Force. Final recommendation statement: Falls prevention in community-dwelling older adults: interventions. Available at: https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/falls-prevention-in-older-adults-interventions1. Accessed May 8, 2018.

US Preventive Services Task Force. Interventions to prevent falls in community-dwelling older adults. US Preventive Services Task Force recommendation statement. JAMA. 2018;319:1696-1704.

Guirguis-Blake JM, Michael YL, Perdue LA, et al. Interventions to prevent falls in older adults. Updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018;319:1705-1716.

Issue
The Journal of Family Practice - 67(6)
Issue
The Journal of Family Practice - 67(6)
Page Number
audio
Page Number
audio
Publications
Publications
Topics
Article Type
Display Headline
USPSTF offers 3 recommendations for preventing falls in older adults
Display Headline
USPSTF offers 3 recommendations for preventing falls in older adults
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Un-Gate On Date
Use ProPublica
CFC Schedule Remove Status
Hide sidebar & use full width
render the right sidebar.

Is the "breast is best" mantra an oversimplification?

Article Type
Changed
Display Headline
Is the "breast is best" mantra an oversimplification?

The benefits of breastfeeding for infants have long been touted as numerous and supported by overwhelming evidence. The World Health Organization (WHO), American College of Obstetricians and Gynecologists, American Academy of Pediatrics (AAP), and American Academy of Family Physicians all strongly recommend exclusive breastfeeding for the first 6 months of life, citing numerous health benefits for child and mother. These groups recommend that some breastfeeding be continued through the first 12 months of life, or longer, as desired (the WHO extends the recommendation to 2 years).1-4 In 2000, the Surgeon General of the United States released a strategic plan to increase rates of breastfeeding,5 setting goals (by 2010) of:

  • 75% of mothers leaving the hospital breastfeeding
  • 50% of babies breastfeeding at 6 months
  • 25% of babies breastfeeding at 1 year.

Massive public health campaigns citing data for the many benefits of breastfeeding have been launched with the goal of increasing the breastfeeding rate. In 2014, statistics offered a testament to the success of these campaigns6:

  • 82.5% of infants had been breastfed “ever”
  • 55.3% were breastfed “some”
  • 24.9% were breastfed exclusively through 6 months of age
  • 33.7% were breastfed “some” at 12 months.

Breastfeeding advocacy has become clouded

In recent years, an increasing number of researchers, physicians, and authors have begun to question whether, in the United States, the benefits of breastfeeding children are exaggerated and the emphasis on breastfeeding might be leading to feelings of inadequacy, guilt, and anxiety among mothers.7-13 In 2016, the US Preventive Services Task Force (USPSTF) amended its recommendation to “promote and support breastfeeding” to simply “support breastfeeding”—a change that created substantial debate and prompted the Task Force to clarify its stance in changing the language: In its response to public comment, the USPSTF said that its position regarding promotion had not changed, but the language in the original statement had been revised to “ensure that the autonomy of women is respected.” 2,14-16

In contrast, others suggest counseling women on the risks of formula feeding rather than on the benefits of breastfeeding, citing substantial health outcome distinctions.17 Indeed, wide-ranging conclusions have been drawn from the same data on the topic, potentially creating uncertainty for physicians on how best to counsel women on their choice of how to feed their infant.

An increasing number of researchers and physicians have begun to question whether the benefits of breastfeeding are exaggerated.

In this article, we address this uncertainty by utilizing the most recent and comprehensive data to examine infant health outcomes. When possible, the number needed to treat (NNT) for a given outcome has been calculated or approximated, allowing the reader to estimate the likelihood of benefit for an individual mother–infant dyad. Exercise caution when interpreting the NNT, however: The numbers suggest causality that cannot be definitively established using the observational data on which those numbers are based.

Continue to: Infectious disease

 

 

Infectious disease

Acute otitis media. Exclusive breastfeeding for 6 months is associated with a 43% reduction in the risk of acute otitis media (AOM) by 2 years of age (odds ratio [OR]=0.57; 95% confidence interval [CI], 0.44-0.75). Beyond 2 years of age, or when comparing “ever” and “never” breastfeeding, the effect disappears. All studies in this meta-analysis had serious limitations.18

Nearly half of children will have at least one case of AOM by one year of age; 80%, by 2 years.19,20 Since the introduction of the heptavalent pneumococcal conjugate vaccine, the rate of AOM at 2 years has fallen by as much as 20%.21 Assuming an incidence of 60% to 80% of AOM by 2 years, only 2 or 3 infants need to be exclusively breastfed for 6 months to prevent a single case of AOM.18 Prevention of AOM through breastfeeding may be related to head position during feeding, antibacterial effects of breast milk, protective oral microbiome in the breastfed infant pharynx, and/or prevention of primary viral upper respiratory infection (URI), which nearly always precedes AOM.18,19

Upper and lower respiratory tract infections. Infants who are exclusively breastfed for 4 months and partially breastfed after 4 months have a lower risk of URI (OR=0.65; 95% CI, 0.51-0.83) and of lower respiratory tract infection (LRTI; OR=0.50; 95% CI, 0.32-0.72).22

The effect is stronger for URI among infants exclusively breastfed for at least 6 months (OR=0.37; 95% CI, 0.18-0.74), but is no longer significant by that time for LRTI (OR=0.33; 95% CI, 0.08-1.40). Importantly, AOM was included in the URI group, and, as previously discussed, AOM has independently been shown to have an inverse relationship with breastfeeding duration.

At 7 to 12 months of age, no association was seen between breastfeeding and the incidence of URI. Curiously, an association with LRTI was again detected for infants breastfed exclusively for 4 months and partially thereafter, but was not detected with exclusive breastfeeding for at least 6 months (OR=0.46; 95% CI, 0.31-0.69). In this study, in the first 6 months of life, 40% of infants had a URI and 8% had an LRTI. The findings in this cohort suggest an NNT of 6 or 7 for prevention of URI and an NNT of 25 for prevention of LRTI in the first 6 months of life.22

Continue to: Children younger than 2 years are...

 

 

Children younger than 2 years are estimated to have approximately 6 bouts of the common cold a year, and essentially 100% have at least one bout—perhaps lowering the NNT for URI if applied widely. However, these data are not divided into 6-month intervals, making accurate extrapolation difficult.23

Gastrointestinal infection. The rate of diarrheal illness in the first year of life is lower in infants who are exclusively breastfed for at least 4 months and partially breastfed after.

Both the Promotion of Breastfeeding Intervention Trial (PROBIT; a clinical trial in which infants were randomized to a breastfeeding education intervention or standard care) and a 2010 prospective cohort study in the Netherlands of more than 3400 infants found a reduction in the risk of one or more gastrointestinal (GI) infections at a similar rate.22,24

  • In PROBIT, 9.1% of infants in the intervention group, compared to 13.2% in the standard care group (OR=0.60; 95% CI, 0.40-0.91), had one or more GI infections at 12 months of age.24
  • In the 2010 Netherlands cohort, 8% of infants had a GI infection by 6 months of age. Infants breastfed exclusively for at least 4 or 6 months had a decreased risk for GI infection (respectively: adjusted OR=0.41; 95% CI, 0.26-0.64 and adjusted OR=0.46; 95% CI, 0.14-1.59). No such association was found for any feeding group 7 to 12 months of age.22

These studies are notable for the low incidence of GI infection, which is frequently cited as 1.3 to 2.3 episodes per child per year in children younger than 3 years in the United States.25 However, that high incidence has likely declined significantly since the introduction of rotavirus vaccine in 2006. In the years following the introduction of the vaccine, infant visits for gastroenteritis decreased by >90% in all care settings in the South, Northeast, and Midwest regions of the United States and by 53% to 63% in the West region.26 Recent accurate epidemiologic information, in an era of significantly higher vaccination rates, is lacking.

Assuming the low incidence of GI infection reported in PROBIT and the Netherlands trials, about 25 to 30 infants need to be exclusively breastfed for 4 to 6 months to prevent a single GI infection during the first 6 to 12 months of life.22,24 Assuming a 60% incidence by age 12 months before introduction of the rotavirus vaccine, the NNT would be approximately 4.24 The true number is likely somewhere between those 2 NNTs.

Continue to: Hospitalization

 

 

Hospitalization

Risk of infection is decreased. A large cohort study in Scotland, involving more than 500,000 children, found an association between exclusive breastfeeding for 6 to 8 weeks and decreased risk of hospitalization within the first 6 months of life. Formula-fed and mixed-fed infants had an increased hazard ratio (HR) for hospitalization for common childhood illness (HR=1.40; 95% CI, 1.35-1.45 for formula-fed infants and HR=1.18; 95% CI, 1.11-1.25 for mixed-fed infants).27 The study also found increased rates of hospitalization for conditions for which other meta-analyses have failed to show a protective effect from breastfeeding—leading to suspicion of residual confounding in the study. Another United Kingdom cohort demonstrated lower rates of hospitalization for GI infection (NNT=171) and LRTI (NNT=115) among exclusively breastfed infants by 8 months of age.28

Risk of neonatal readmission is increased. Late preterm infants who are exclusively breastfed are nearly twice as likely to be hospitalized as breastfed term or non-breastfed preterm infants, primarily due to dehydration, failure to thrive, weight loss, and hyperbilirubinemia. In fact, exclusive breastfeeding at discharge from the hospital is likely the single greatest risk factor for hospital readmission in newborns.29,30 Term infants who are exclusively breastfed are more likely to be hospitalized compared to formula-fed or mixed-fed infants, due to hyperbilirubinemia, dehydration, hypernatremia, and weight loss (number needed to harm (NNH)=71).30-32 For weight loss >10% of birth weight with or without hospitalization, the NNH for breastfed infants is 13.32

 

Many of these hospitalizations and events could be avoided with appropriate monitoring and medically indicated supplementation; the likelihood of long-term harm is low. Formula supplementation is often avoided if possible in hospitals to promote exclusive breastfeeding; however, several small randomized clinical trials have demonstrated that limited formula supplementation in breastfed infants does not affect the breastfeeding continuation rate at 3 and 6 months, and, therefore, might be a way to decrease infant rehospitalization.33,34

Necrotizing enterocolitis

Exclusive breastfeeding for 6 months is associated with a 43% reduction in the risk of acute otitis media by 2 years of age.

In preterm infants, breastfeeding has been associated with a lower rate of necrotizing enterocolitis. In the 2007 Agency for Healthcare Research and Quality report, the association was found to be only marginally statistically significant, and the authors warned that, first, evidence is old and heterogeneous and, second, present preterm formula is much different than the formula used in earlier studies of preterm infant nutrition and necrotizing enterocolitis.35 A 2012 Cochrane review included newer studies in its analysis but reached the same conclusion on the quality and heterogeneity of available evidence, with a NNT of 25.36

Continue to: Sudden infant death syndrome

 

 

Sudden infant death syndrome

There is a statistically significant association between sudden infant death syndrome (SIDS) and feeding method. Infants whose cause of death is SIDS are approximately one half as likely to have been breastfed as matched controls.35,37

In 2005, AAP did not recommend breastfeeding as a means to reduce the risk of SIDS because available evidence was mixed, and studies at the time were poorly controlled.38 Since that time, case-control meta-analyses have shed additional light on the association between SIDS and feeding method.35,37

The protective effect exists for any amount of breastfeeding and is stronger for exclusive breastfeeding, suggesting a protective role—not simply an association. Caution should be employed with this conclusion, however, because the studies included in the meta-analysis used univariate analysis primarily and did not control sufficiently for known confounders. In addition, the authors warn that publication bias might overestimate the association.38

Exclusive breastfeeding is likely the single greatest risk factor for hospital readmission in newborns.

Potential mechanisms of a protective role include decreased risk of infection and greater arousability from sleep in breastfed infants. Assuming a protective role, available data suggest that more than 3500 infants need to be breastfed to prevent one case of SIDS.39

Continue to: Allergic disease

 

 

Allergic disease

Asthma. There is evidence of a small protective effect of breastfeeding “ever” on asthma at 5 to 18 years of age in high-income countries (OR=0.90; 95% CI, 0.83-0.97). A family history of asthma or atopy did not affect this finding. The authors note there is some evidence of publication bias in this review, which is the largest and most comprehensive on the topic.40

With a lifetime prevalence of asthma in the United States of approximately 13.2%, this association would confer an NNT of roughly 76.41 Earlier, the literature demonstrated mixed and conflicting evidence, and some experts suggested an effect only when there is a family history of asthma or atopy.36

Eczema. For children younger than 2 years, there is low-grade- and very-low-grade-quality evidence that exclusive breastfeeding longer than 3 to 4 months is associated with a reduced risk of eczema (OR=0.74; 95% CI, 0.57-0.97).40

Previously, data suggested that this association existed only in children who had a family history of atopy.35 The protective association, however, exists regardless of family history and does not persist beyond 2 years of age. The authors noted evidence of publication bias, reverse causation, and misdiagnosis of early childhood rashes as eczema as limitations of their findings.40

Continue to: Reliable epidemiologic evidence...

 

 

Reliable epidemiologic evidence on the incidence of eczema in infants in the United States is limited, but the prevalence in the United States in children younger than 17 years is approximately 10.7% (with wide regional variation). Extrapolating these data generously, the NNT to prevent eczema in the first 2 years of life could be estimated at approximately 36.42

Allergic rhinitis. There is low-grade- and very-low-grade-quality evidence that more breastfeeding, compared to less breastfeeding, is associated with a lower risk of allergic rhinitis in children younger than 5 years (OR=0.79; 95% CI, 0.63-0.98). The association exists regardless of family history and disappears after 5 years of age. The differentiation of allergic rhinitis from rhinovirus infection (for which there is higher-quality evidence of a protective effect with breastfeeding) must be considered when interpreting these data.40

Reliable epidemiologic evidence on allergic rhinitis in children younger than 5 years is lacking, and incidence varies by region. A rough estimate, using data from 6- and 7-year-olds, indicates an NNT of 54 to 70.43

Food allergy. There is no evidence to suggest an association between breastfeeding and food allergy, either as protective or as a risk factor, and studies are limited.40 Interestingly, as data accumulate associating early exposure to foods with protection, some authors have proposed reexamining the recommendation from WHO and US health organizations for exclusive breastfeeding for the first 6 months of life.7,44

Continue to: Dental health

 

 

Dental health

Dental caries. There is consistent evidence that breastfeeding beyond 12 months of age is associated with the development of dental caries of deciduous teeth to 6 years of age (OR=2.90; 95% CI, 2.33-3.60). Many of the studies that showed this association did not control for the introduction of sugary foods and drinks, and there was a trend toward publication bias showing the association.45

Dental malocclusion. There is consistent evidence for approximately a two-thirds reduction in malocclusions in deciduous teeth in breastfed infants (OR=0.32; 95% CI, 0.25-0.40). Although the large majority of these data come from low-income and middle-income countries, the incidence of malocclusion is not thought to be associated with socioeconomic status, as so many other breastfeeding outcomes are.46

Childhood leukemia

In the largest meta-analysis available, a statistically significant inverse relationship between any breastfeeding for >6 months and childhood leukemia is evident in developed countries (OR=0.84; 95% CI, 0.78-0.91), although significant heterogeneity among studies and lack of control for confounding variables are significant limitations. In particular, an association has been demonstrated with acute lymphoblastic leukemia (ALL) but not with acute myelogenous leukemia.47 Given the rarity of childhood ALL, approximately 12,500 infants would need to be breastfed to prevent one case.48

Continue to: Long-term outcomes

 

 

Long-term outcomes

Cognitive development. Several studies conducted in developed countries have linked breastfeeding to positive cognitive outcomes in children, including higher intelligence quotient (IQ).35,49-52

These effects are conflicting, however, in studies that include sibling analysis and ones that control for maternal IQ.8,35,43,52-54 In the 2013 WHO meta-analysis, breastfeeding was associated with an increase of 2.2 points on normalized testing when only high-quality studies were included.51 A 2015 meta-analysis identified 4 high-quality studies with a large sample size and recall time <3 years, which demonstrated a mean difference of 1.76 points in IQ (95% CI, 0.25-3.26) in childhood and adolescence.52 Although statistically significant, this modest increase is of questionable clinical benefit and of unknown duration.

 

Obesity. The relationship between breastfeeding and obesity later in life is debatable. A large, systematic 2014 review of 15 cohort and 10 cross-sectional studies found a significantly reduced risk of childhood obesity among children who were breastfed (adjusted OR=0.78; 95% CI, 0.74-0.81).55 However, the review included studies that controlled for different confounders, and smaller effects were found in studies in which more confounders were taken into account.

Available data suggest that more than 3500 infants need to be breastfed to prevent one case of SIDS.

The 2013 WHO meta-analysis found a small (approximately 10%) reduction in the prevalence of overweight or obese children, but cautioned that residual confounding and publication bias were likely.51 At 6.5 and 11.5 years of follow-up, PROBIT failed to demonstrate a protective effect for exclusively or “ever” breastfed infants.56 Sibling analysis similarly fails to demonstrate a statistically significant relationship.8

Continue to: A 2015 meta-analysis of 23 high-quality studies...

 

 

A 2015 meta-analysis of 23 high-quality studies with a sample size >1500 children and controlled for important confounders showed a pooled reduction in the prevalence of overweight or obesity of 13% (95% CI, 6-19).57 The protection in this meta-analysis showed a dilution of the effect as the participants aged and an inverse relationship of the effect with sample size.

Breastfeeding is, therefore, unlikely to play a significant, if any, role in combatting the obesity epidemic.

Hypertension. A meta-analysis of high-quality trials demonstrates a <1 mm Hg reduction in systolic blood pressure and no significant difference in diastolic pressure in breastfed infants.57 Similarly, no significant effect of breastfeeding on blood pressure has been demonstrated in trials of preterm infants.51

Type 2 diabetes. Available data are limited and heterogeneous for the association between breastfeeding and later development of type 2 diabetes. Only 2 high-quality trials were identified in the 2013 WHO meta-analysis, and their results conflict.51 A 2015 meta-analysis identified only 3 high-quality studies, without a statistically significant relationship.57

Dyslipidemia. Although earlier data suggested an association between breastfeeding and reduced cholesterol levels later in life, the 2013 WHO meta-analysis and a 2015 meta-analysis concluded that no association exists. The limited data available for preterm infants conflict.51,57

Growth. There is no evidence that feeding method has a short- or long-term effect on weight gain or length gain in preterm or term infants.35,36,58

Death. No clear association has been found between mortality and breastfeeding status in developed countries, except for the association with SIDS.35

Continue to: What issues frame and guide counseling on breastfeeding?

 

 

What issues frame and guide counseling on breastfeeding?

There is that “problem” with the evidence. The evidence for infant breastfeeding status and its association with health outcomes faces significant limitations; the great majority of those limitations tend to overestimate the benefits of breastfeeding. Nearly all evidence is based on observational studies, in which causality cannot be determined and self-selection bias, recall bias, and residual confounding limit the value or strength of the findings.

The use of pacifiers before last sleep is more protective against SIDS than breastfeeding.

Breastfeeding rates are strongly socially patterned alongside socioeconomic status, race, and education level, all of which are simultaneously strongly tied to short- and long-term health outcomes.6 Other factors limiting the strength of the data set include varying definitions of infant feeding practices in different studies, varying definitions of outcomes and diseases, reverse causation, and evidence of publication bias in many meta-analyses. Given these shortcomings, the NNTs in this article probably represent a best-case scenario for breastfeeding outcomes for infants in the United States (TABLE 118,22-24,28,36,39-43,47,48).

Breastfeeding NNT to achieve short-term infant health varies widely

Data need to be put into context. The NNTs for many breastfeeding outcomes (TABLE) compare favorably with other recommended interventions, particularly for other preventive care measures. Two examples: 81 mg/d aspirin for a 50-year-old man has an NNT of 35 to 45 for preventing nonfatal myocardial infarction, and the number needed to invite to screen with mammography to prevent one breast cancer death for a 50-year-old woman is 1339.59,60

In both of these examples, >95% of patients will not benefit from the intervention, yet these preventive measures are routinely recommended and have a significant impact at the public health level. Notably, these outcomes are more serious than most breastfeeding outcomes; have a longer-lasting effect, better-quality data, and better data for potential harms; are causally linked to the intervention; and require much less effort and commitment of time than breastfeeding.

The question must be reckoned with: Can advocacy be harmful?

In recent years, a growing number of concerns have been raised about:

  • the potential harms of breastfeeding advocacy
  • exaggeration of the benefits of breastfeeding
  • promotion of breastfeeding at the expense of evidence-based medicine.

The “Ten Steps to Successful Breastfeeding” program of the Baby-friendly Hospital Initiative (BFHI; launched by UNICEF and WHO) has come under scrutiny because of an increasing number of reports of sudden unexpected postnatal collapse; fall injuries; modeling and encouragement of unsafe sleep practices; an overly rigid resistance to the use of formula supplementation; and the ban on pacifier use.61,62 The BFHI, promoted by the Centers for Disease Control and Prevention, is increasingly being adopted by hospitals with the expressed goal of increasing the breastfeeding rate from birth to discharge.

Continue to: Some of the "Ten Steps"...

 

 

Some of the “Ten Steps,” such as the call for skin-to-skin care and 24-hour rooming-in, have well-established benefit yet, when performed without supervision, can have the rare but serious unintended consequences of sudden unexpected postnatal collapse (the incidence of which may be higher than that of SIDS) and unsafe sleeping practices.62,63

Furthermore, despite evidence that early formula supplementation, when medically necessary, does not adversely impact the breastfeeding rate, the “Ten Steps” program advises that giving formula before breast milk comes in might “lead to failure to breastfeed.”33,34,61,63

Similarly, the ban on pacifiers is contrary to available evidence. The use of pacifiers before last sleep is more protective against SIDS than breastfeeding (NNT=2733), and there is evidence at one hospital that BFHI-inspired pacifier restriction is associated with a decrease in the rate of breastfeeding.64,65

Other harms of advocacy are even more poorly studied. Most of the evidence for harm comes from the psychology and social science literature—not the medical literature, perhaps because the prevailing opinion in the medical community is that breastfeeding has overwhelming evidence for benefit. In fact, in the USPSTF’s 2008 recommendation, the evidence review of breastfeeding promotion practices in primary care did not identify a single study that measured harm; in the 2016 update of that recommendation, only 2 such studies were identified.15,66

The literature that does investigate harm consistently finds that women who have difficulty breastfeeding or choose formula feeding report feelings of inadequacy, guilt, loss of agency, anxiety, and physical pain during breastfeeding that interferes with 1) their ability to bond or otherwise care for their infant and 2) competing work obligations.11-13,67-69 Given the lack of attention paid to these variables in the medical literature, it is the individual mother who is best positioned to weigh these factors against the benefits of breastfeeding.

Continue to: Shared decision-making is best—for mother and baby

 

 

Shared decision-making is best—for mother and baby

Breastfeeding might prevent certain infections in as many as 50% of infants, but a mother unable to breastfeed can take solace in the fact that >95% of breastfed infants will not realize any benefit from the preventive potential of breastfeeding in regard to hospitalization or allergic disease, and >99% will not realize benefit from either the prevention of SIDS or ALL, or from improvement in long-term health measures (except for, perhaps, a slightly higher IQ). The “breast is best” mantra is likely true at a public-health level; for the individual mother–infant dyad, however, where there is a need to balance personal, social, family, and financial factors, that mantra is an oversimplification.

The "breast is best" mantra is likely true at a public- health level; for the individual mother-infant dyad, however, that mantra is oversimplified.

Regrettably, there is a paucity of data on the risks of breastfeeding promotion—an area that deserves more study. Balancing the abundant, but often limited-quality, data on the benefits of breastfeeding and the sheer lack of data regarding the risks of advocacy represents a clinical and an ethical challenge for physicians. It is a challenge that can only be resolved through individualization of care and shared decision-making, in which the physician is expert on the benefits of breastfeeding, and the mother is expert on the personal circumstances to be weighed against those benefits.

CORRESPONDENCE
Joseph Lane Wilson, MD, ECU Brody School of Medicine, Department of Family Medicine, 101 Heart Drive, Greenville, NC 27834; [email protected].

References

1. Global Strategy for Infant and Young Child Feeding. Geneva, Switzerland: World Health Organization, and New York, NY: UNICEF; 2003. Available at: www.who.int/maternal_child_adolescent/documents/9241562218/en/. Accessed April 4, 2018.

2. American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice; Breastfeeding Expert Work Group. Committee Opinion No. 658: Optimizing support for breastfeeding as part of obstetric practice. Obstet Gynecol. 2016;127:e86-e92.

3. Gartner LM, Morton J, Lawrence RA, et al; American Academy of Pediatrics Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics. 2005;115:496-506.

4. Breastfeeding (policy statement). Leawood, KS: American Academy of Family Physicians; 2007. Available at: https://www.aafp.org/about/policies/all/breastfeeding.html. Accessed April 3, 2018.

5. Office of the Surgeon General (US); Centers for Disease Control and Prevention (US); Office on Women’s Health (US). The Surgeon General’s call to action to support breastfeeding. Rockville, MD: US Department of Health and Human Services; 2011. Available at: www.surgeongeneral.gov/library/calls/breastfeeding/index.html. Updated August 12, 2014. Accessed April 4, 2018.

6. Breastfeeding: data & statistics. Atlanta, GA: Centers for Disease Control and Prevention; December 11, 2017. Available at: http://www.cdc.gov/breastfeeding/data/. Accessed May 17, 2018.

7. Fewtrell M, Wilson DC, Booth I, et al. A. Six months of exclusive breast feeding: how good is the evidence? BMJ. 2010;342:c5955.

8. Colen CG, Ramey DM. Is breast truly best? Estimating the effect of breastfeeding on long-term child wellbeing in the United States using sibling comparisons. Soc Sci Med. 2014;109:55-65.

9. Wolf J. Is Breast Best? Taking on the Breastfeeding Experts and the New High Stakes of Motherhood. New York, NY: NYU Press; 2010.

10. Tuteur A. Push Back: Guilt in the Age of Natural Parenting. New York, NY: HarperCollins Publishers; 2016.

11. Lee E. Health, morality, and infant feeding: British mothers’ experiences of formula milk use in the early weeks. Sociol Health Illn. 2007;29:1075-1090.

12. Williams K, Donaghue N, Kurz T. “Giving guilt the flick”?: an investigation of mothers’ talk about guilt in relation to infant feeding. Psychol Women Q. 2013;37:97-112.

13. Fahlquist JN, Roeser S. Ethical problems with information on infant feeding in developed countries. J Health Polit Policy Law. 2012;37:155-160.

14. U.S. Preventive Services Task Force. Final Recommendation Statement. Breastfeeding: Counseling. Available at: www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/breastfeeding-counseling. Accessed April 4, 2018.

15. US Preventive Services Task Force. Primary Care Interventions to Support Breastfeeding: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;316:1688-1693.

16. Zahn CM, Hanley LE. Concerns over USPSTF draft recommendation on breastfeeding interventions [letter]. Washington, DC: The American College of Obstetricians and Gynecologists; May 18, 2016. Available at: https://www.acog.org/-/media/Departments/Breastfeeding/Breast-Feeding-ACOG-USPSTF.pdf?dmc=1&ts=20180518T1850056558. Accessed May 22, 2018.

17. Stuebe A. The risks of not breastfeeding for mothers and infants. Rev Obstet Gynecol. 2009;2:222-231.

18. Bowatte G, Tham R, Allen KJ, et al. Breastfeeding and childhood acute otitis media: a systematic review and meta-analysis. Acta Paediatr. 2015;104:85-95.

19. Chonmaitree T, Trujillo R, Jennings K, et al. Acute otitis media and other complications of viral respiratory infection. Pediatrics. 2016;137:e20153555.

20. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis. 1989;160:83-94.

21. Grijalva CG, Poehling KA, Nuorti JP, et al. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics. 2006;118:865-873.

22. Duijts L, Jaddoe VW, Hofman A, et al. Prolonged and exclusive breastfeeding reduces the risk of infectious diseases in infancy. Pediatrics. 2010;126:e18-e25.

23. Allan GM, Arroll B. Prevention and treatment of the common cold: making sense of the evidence. CMAJ. 2014;186:190-199.

24. Kramer MS, Chalmers B, Hodnett ED, et al; PROBIT Study Group (Promotion of Breastfeeding Intervention Trial). Promotion of Breastfeeding Intervention Trial (PROBIT): a randomized trial in the Republic of Belarus. JAMA. 2001;285:413-420.

25. Dennehy PH. Acute diarrheal disease in children: epidemiology, prevention, and treatment. Infect Dis Clin North Am. 2005;19:585-602.

26. Cortese MM, Tate JE, Simonsen L, et al. Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases. Pediatric Infect Dis J. 2010;29:489-494.

27. Ajetunmobi OM, Whyte B, Chalmers J, et al. Breastfeeding is associated with reduced childhood hospitalization: evidence from a Scottish birth cohort (1997-2009). J Pediatr. 2015;166:620-625.

28. Quigley MA, Kelly YJ, Sacker A. Breastfeeding and hospitalization for diarrheal and respiratory infection in the United Kingdom Millennium Cohort Study. Pediatrics. 2007;119:e837-e842.

29. Radtke JV. The paradox of breastfeeding-associated morbidity among late preterm infants. J Obstet Gynecol Neonatal Nurs. 2011;40:9-24.

30. Escobar GJ, Gonzales VM, Armstrong M, et al. Rehospitalization for neonatal dehydration: a nested case-control study. Arch Pediatr Adolesc Med. 2002;156:155-161.

31. Salas AA, Salazar J, Burgoa CV, et al. Significant weight loss in breastfed term infants readmitted for hyperbilirubinemia. BMC Pediatr. 2009;9:82.

32. Tarcan A, Tiker F, Vatandaş NS, et al. Weight loss and hypernatremia in breast-fed babies: frequency in neonates with non-hemolytic jaundice. J Paediatr Child Health. 2005;41:484-487.

33. Flaherman VJ, Aby J, Burgos AE, et al. Effect of early limited formula on duration and exclusivity of breastfeeding in at-risk infants: an RCT. Pediatrics. 2013;131:1059-1065.

34. Straňák Z, Feyereislova S, Černá M, et al. J. Limited amount of formula may facilitate breastfeeding: randomized, controlled trial to compare standard clinical practice versus limited supplemental feeding. Denning PW, ed. PLoS One. 2016;11:e0150053.

35. Ip S, Chung M, Raman G, et al. Breastfeeding and Maternal and Infant Health Outcomes in Developed Countries. Rockville, MD: Agency for Healthcare Research and Quality (US); 2007. Evidence Reports/Technology Assessments, No. 153. Available at: www.ncbi.nlm.nih.gov/books/NBK38337/. Accessed April 3, 2018.

36. Quigley M, McGuire W. Formula versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev. 2014;(4):CD002971.

37. Hauck FR, Thompson JM, Tanabe KO, et al. Breastfeeding and reduced risk of sudden infant death syndrome: a meta-analysis. Pediatrics. 2011;128:103-110.

38. American Academy of Pediatrics Task Force on Sudden Infant Death Syndrome. The changing concept of sudden infant death syndrome: diagnostic coding shifts, controversies regarding the sleeping environment, and new variables to consider in reducing risk. Pediatrics. 2005;116:1245-1255.

39. Moon RY, Fu L. Sudden infant death syndrome: an update. Pediatr Rev. 2012;33:314-320.

40. Lodge CJ, Tan DJ, Lau MX, et al. Breastfeeding and asthma and allergies: a systematic review and meta-analysis. Acta Paediatr. 2015;104:38-53.

41. Brim SN, Rudd RA, Funk RH, et al. Asthma prevalence among US children in underrepresented minority populations: American Indian/Alaska Native, Chinese, Filipino, and Asian Indian. Pediatrics. 2008;122:e217-e222.

42. Shaw TF, Currie GP, Koudelka CW, et al. Eczema prevalence in the United States: data from the 2003 National Survey of Children’s Health. J Invest Dermatol. 2011;131:67-73.

43. Mallol J, Crane J, von Mutius E, et al. The international study of asthma and allergies in childhood (ISAAC) Phase Three: a global synthesis. Allergol Immunopathol (Madr). 2013;41:73-85.

44. Flohr C, Nagel G, Weinmayr G, et al. Lack of evidence for a protective effect of prolonged breastfeeding on childhood eczema: lessons from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two. Br J Dermatol. 2011;165:1280-1289.

45. Tham R, Bowatte G, Dharmage SC, et al. Breastfeeding and the risk of dental caries: a systematic review and meta-analysis. Acta Paediatr. 2015;104:62-84.

46. Peres KG, Cascaes AM, Nascimento GG, et al. Effect of breastfeeding on malocclusions: a systematic review and meta-analysis. Acta Paediatr. 2015;104:54-61.

47. Amitya EL, Keinan-Boker L. Breastfeeding and childhood leukemia incidence: a meta-analysis and systematic review. JAMA Pediatr. 2015;169:e151025.

48. Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. Lancet. 2013;381:1943-1955.

49. Guxens M, Mendez MA, Moltó-Puigmartí C, et al. Breastfeeding, long-chain polyunsaturated fatty acids in colostrum, and infant mental development.

2012;129:1134-1140.

51. Horta BL, Victora CG. Long-term effects of breastfeeding: a systematic review. Geneva, Switzerland: World Health Organization; 2013. Available at: http://apps.who.int/iris/bitstream/10665/79198/1/9789241505307_eng.pdf. Accessed August 16, 2016.

52. Horta BL, Loret de Mola C, Victora CG. Breastfeeding and intelligence: a systematic review and meta-analysis. Acta Paediatr. 2015;104:14-19.

53. Der G, Batty GD, Deary IJ. Effect of breast feeding on intelligence in children: prospective study, sibling pairs analysis, and meta-analysis. BMJ. 2006;333:945.

54. Sajjad A, Tharner A, Kiefte-de Jong JC, et al. Breastfeeding duration and non-verbal IQ in children. J Epidemiol Community Health 2015;69:775-781.

55. Yan J, Liu L, Zhu Y, et al. The association between breastfeeding and childhood obesity: a meta-analysis. BMC Public Health. 2014;14:1267.

56. Martin RM, Patel R, Kramer MS, et al. Effects of promoting longer-term and exclusive breastfeeding on adiposity and insulin-like growth factor-I at age 11.5 years: a randomized trial. JAMA. 2013;309:1005-1013.

57. Horta BL, Loret de Mola C, Victora CG. Long-term consequences of breastfeeding on cholesterol, obesity, systolic blood pressure, and type 2 diabetes: systematic review and meta-analysis. Acta Paediatr. 2015;104:30-37.

58. Kramer MS, Kakuma R. Optimal duration of exclusive breastfeeding. Cochrane Database of Syst Rev. 2012;15:CD003517.

59. U.S. Preventive Services Task Force. Final recommendation statement: aspirin use to prevent cardiovascular disease and colorectal cancer: preventive medication. Available at: www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/aspirin-to-prevent-cardiovascular-disease-and-cancer. Published September 2017. Accessed April 3, 2018.

60. U.S. Preventive Services Task Force. Screening for breast cancer. Available at: www.uspreventiveservicestaskforce.org/Page/SupportingDoc/breast-cancer-screening/final-evidence-summary9. Published November 2009. Accessed April 2, 2018.

61. Bass JL, Gartley T, Kleinman R. Unintended consequences of current breastfeeding initiatives. JAMA Pediatr. 2016;170:923-924.

62. Feldman-Winter L, Goldsmith JP; Committee on Fetus and Newborn; Task Force on Sudden Infant Death Syndrome. Safe sleep and skin-to-skin care in the neonatal period for healthy term newborns. Pediatrics. 2016;138:e20161889.

63. The Mother and Child Health and Education Trust. Ten steps to successful breastfeeding. Available at: www.tensteps.org. Published November 8, 2017. Accessed April 3, 2018.

64. Hauck FR, Omojokun OO, Siadaty MS. Do pacifiers reduce the risk of sudden infant death syndrome? A meta-analysis. Pediatrics. 2005;116:e716-e723.

65. Kair LR, Kenron D, Etheredge K, et al. Pacifier restriction and exclusive breastfeeding. Pediatrics. 2013;131:e1101-e1107.

66. Chung M, Raman G, Trikalinos T, et al. Interventions in primary care to promote breastfeeding: an evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:565-582.

67. Wolf JB. Is breast really best? Risk and total motherhood in the National Breastfeeding Awareness Campaign. J Health Polit Policy Law. 2007;32:595-636.

68. Marshall JL, Godfrey M, Renfrew MJ. Being a ‘good mother’: managing breastfeeding and merging identities. Soc Sci Med. 2007;65:2147-2159.

69. Kelleher CM. The physical challenges of early breastfeeding. Soc Sci Med. 2006;63:2727-2738.

Article PDF
Author and Disclosure Information

Department of Family Medicine, East Carolina University Brody School of Medicine, Greenville, NC
[email protected]

The authors reported no potential conflict of interest relevant to this article.

Issue
The Journal of Family Practice - 67(6)
Publications
Topics
Page Number
E1-E9
Sections
Author and Disclosure Information

Department of Family Medicine, East Carolina University Brody School of Medicine, Greenville, NC
[email protected]

The authors reported no potential conflict of interest relevant to this article.

Author and Disclosure Information

Department of Family Medicine, East Carolina University Brody School of Medicine, Greenville, NC
[email protected]

The authors reported no potential conflict of interest relevant to this article.

Article PDF
Article PDF

The benefits of breastfeeding for infants have long been touted as numerous and supported by overwhelming evidence. The World Health Organization (WHO), American College of Obstetricians and Gynecologists, American Academy of Pediatrics (AAP), and American Academy of Family Physicians all strongly recommend exclusive breastfeeding for the first 6 months of life, citing numerous health benefits for child and mother. These groups recommend that some breastfeeding be continued through the first 12 months of life, or longer, as desired (the WHO extends the recommendation to 2 years).1-4 In 2000, the Surgeon General of the United States released a strategic plan to increase rates of breastfeeding,5 setting goals (by 2010) of:

  • 75% of mothers leaving the hospital breastfeeding
  • 50% of babies breastfeeding at 6 months
  • 25% of babies breastfeeding at 1 year.

Massive public health campaigns citing data for the many benefits of breastfeeding have been launched with the goal of increasing the breastfeeding rate. In 2014, statistics offered a testament to the success of these campaigns6:

  • 82.5% of infants had been breastfed “ever”
  • 55.3% were breastfed “some”
  • 24.9% were breastfed exclusively through 6 months of age
  • 33.7% were breastfed “some” at 12 months.

Breastfeeding advocacy has become clouded

In recent years, an increasing number of researchers, physicians, and authors have begun to question whether, in the United States, the benefits of breastfeeding children are exaggerated and the emphasis on breastfeeding might be leading to feelings of inadequacy, guilt, and anxiety among mothers.7-13 In 2016, the US Preventive Services Task Force (USPSTF) amended its recommendation to “promote and support breastfeeding” to simply “support breastfeeding”—a change that created substantial debate and prompted the Task Force to clarify its stance in changing the language: In its response to public comment, the USPSTF said that its position regarding promotion had not changed, but the language in the original statement had been revised to “ensure that the autonomy of women is respected.” 2,14-16

In contrast, others suggest counseling women on the risks of formula feeding rather than on the benefits of breastfeeding, citing substantial health outcome distinctions.17 Indeed, wide-ranging conclusions have been drawn from the same data on the topic, potentially creating uncertainty for physicians on how best to counsel women on their choice of how to feed their infant.

An increasing number of researchers and physicians have begun to question whether the benefits of breastfeeding are exaggerated.

In this article, we address this uncertainty by utilizing the most recent and comprehensive data to examine infant health outcomes. When possible, the number needed to treat (NNT) for a given outcome has been calculated or approximated, allowing the reader to estimate the likelihood of benefit for an individual mother–infant dyad. Exercise caution when interpreting the NNT, however: The numbers suggest causality that cannot be definitively established using the observational data on which those numbers are based.

Continue to: Infectious disease

 

 

Infectious disease

Acute otitis media. Exclusive breastfeeding for 6 months is associated with a 43% reduction in the risk of acute otitis media (AOM) by 2 years of age (odds ratio [OR]=0.57; 95% confidence interval [CI], 0.44-0.75). Beyond 2 years of age, or when comparing “ever” and “never” breastfeeding, the effect disappears. All studies in this meta-analysis had serious limitations.18

Nearly half of children will have at least one case of AOM by one year of age; 80%, by 2 years.19,20 Since the introduction of the heptavalent pneumococcal conjugate vaccine, the rate of AOM at 2 years has fallen by as much as 20%.21 Assuming an incidence of 60% to 80% of AOM by 2 years, only 2 or 3 infants need to be exclusively breastfed for 6 months to prevent a single case of AOM.18 Prevention of AOM through breastfeeding may be related to head position during feeding, antibacterial effects of breast milk, protective oral microbiome in the breastfed infant pharynx, and/or prevention of primary viral upper respiratory infection (URI), which nearly always precedes AOM.18,19

Upper and lower respiratory tract infections. Infants who are exclusively breastfed for 4 months and partially breastfed after 4 months have a lower risk of URI (OR=0.65; 95% CI, 0.51-0.83) and of lower respiratory tract infection (LRTI; OR=0.50; 95% CI, 0.32-0.72).22

The effect is stronger for URI among infants exclusively breastfed for at least 6 months (OR=0.37; 95% CI, 0.18-0.74), but is no longer significant by that time for LRTI (OR=0.33; 95% CI, 0.08-1.40). Importantly, AOM was included in the URI group, and, as previously discussed, AOM has independently been shown to have an inverse relationship with breastfeeding duration.

At 7 to 12 months of age, no association was seen between breastfeeding and the incidence of URI. Curiously, an association with LRTI was again detected for infants breastfed exclusively for 4 months and partially thereafter, but was not detected with exclusive breastfeeding for at least 6 months (OR=0.46; 95% CI, 0.31-0.69). In this study, in the first 6 months of life, 40% of infants had a URI and 8% had an LRTI. The findings in this cohort suggest an NNT of 6 or 7 for prevention of URI and an NNT of 25 for prevention of LRTI in the first 6 months of life.22

Continue to: Children younger than 2 years are...

 

 

Children younger than 2 years are estimated to have approximately 6 bouts of the common cold a year, and essentially 100% have at least one bout—perhaps lowering the NNT for URI if applied widely. However, these data are not divided into 6-month intervals, making accurate extrapolation difficult.23

Gastrointestinal infection. The rate of diarrheal illness in the first year of life is lower in infants who are exclusively breastfed for at least 4 months and partially breastfed after.

Both the Promotion of Breastfeeding Intervention Trial (PROBIT; a clinical trial in which infants were randomized to a breastfeeding education intervention or standard care) and a 2010 prospective cohort study in the Netherlands of more than 3400 infants found a reduction in the risk of one or more gastrointestinal (GI) infections at a similar rate.22,24

  • In PROBIT, 9.1% of infants in the intervention group, compared to 13.2% in the standard care group (OR=0.60; 95% CI, 0.40-0.91), had one or more GI infections at 12 months of age.24
  • In the 2010 Netherlands cohort, 8% of infants had a GI infection by 6 months of age. Infants breastfed exclusively for at least 4 or 6 months had a decreased risk for GI infection (respectively: adjusted OR=0.41; 95% CI, 0.26-0.64 and adjusted OR=0.46; 95% CI, 0.14-1.59). No such association was found for any feeding group 7 to 12 months of age.22

These studies are notable for the low incidence of GI infection, which is frequently cited as 1.3 to 2.3 episodes per child per year in children younger than 3 years in the United States.25 However, that high incidence has likely declined significantly since the introduction of rotavirus vaccine in 2006. In the years following the introduction of the vaccine, infant visits for gastroenteritis decreased by >90% in all care settings in the South, Northeast, and Midwest regions of the United States and by 53% to 63% in the West region.26 Recent accurate epidemiologic information, in an era of significantly higher vaccination rates, is lacking.

Assuming the low incidence of GI infection reported in PROBIT and the Netherlands trials, about 25 to 30 infants need to be exclusively breastfed for 4 to 6 months to prevent a single GI infection during the first 6 to 12 months of life.22,24 Assuming a 60% incidence by age 12 months before introduction of the rotavirus vaccine, the NNT would be approximately 4.24 The true number is likely somewhere between those 2 NNTs.

Continue to: Hospitalization

 

 

Hospitalization

Risk of infection is decreased. A large cohort study in Scotland, involving more than 500,000 children, found an association between exclusive breastfeeding for 6 to 8 weeks and decreased risk of hospitalization within the first 6 months of life. Formula-fed and mixed-fed infants had an increased hazard ratio (HR) for hospitalization for common childhood illness (HR=1.40; 95% CI, 1.35-1.45 for formula-fed infants and HR=1.18; 95% CI, 1.11-1.25 for mixed-fed infants).27 The study also found increased rates of hospitalization for conditions for which other meta-analyses have failed to show a protective effect from breastfeeding—leading to suspicion of residual confounding in the study. Another United Kingdom cohort demonstrated lower rates of hospitalization for GI infection (NNT=171) and LRTI (NNT=115) among exclusively breastfed infants by 8 months of age.28

Risk of neonatal readmission is increased. Late preterm infants who are exclusively breastfed are nearly twice as likely to be hospitalized as breastfed term or non-breastfed preterm infants, primarily due to dehydration, failure to thrive, weight loss, and hyperbilirubinemia. In fact, exclusive breastfeeding at discharge from the hospital is likely the single greatest risk factor for hospital readmission in newborns.29,30 Term infants who are exclusively breastfed are more likely to be hospitalized compared to formula-fed or mixed-fed infants, due to hyperbilirubinemia, dehydration, hypernatremia, and weight loss (number needed to harm (NNH)=71).30-32 For weight loss >10% of birth weight with or without hospitalization, the NNH for breastfed infants is 13.32

 

Many of these hospitalizations and events could be avoided with appropriate monitoring and medically indicated supplementation; the likelihood of long-term harm is low. Formula supplementation is often avoided if possible in hospitals to promote exclusive breastfeeding; however, several small randomized clinical trials have demonstrated that limited formula supplementation in breastfed infants does not affect the breastfeeding continuation rate at 3 and 6 months, and, therefore, might be a way to decrease infant rehospitalization.33,34

Necrotizing enterocolitis

Exclusive breastfeeding for 6 months is associated with a 43% reduction in the risk of acute otitis media by 2 years of age.

In preterm infants, breastfeeding has been associated with a lower rate of necrotizing enterocolitis. In the 2007 Agency for Healthcare Research and Quality report, the association was found to be only marginally statistically significant, and the authors warned that, first, evidence is old and heterogeneous and, second, present preterm formula is much different than the formula used in earlier studies of preterm infant nutrition and necrotizing enterocolitis.35 A 2012 Cochrane review included newer studies in its analysis but reached the same conclusion on the quality and heterogeneity of available evidence, with a NNT of 25.36

Continue to: Sudden infant death syndrome

 

 

Sudden infant death syndrome

There is a statistically significant association between sudden infant death syndrome (SIDS) and feeding method. Infants whose cause of death is SIDS are approximately one half as likely to have been breastfed as matched controls.35,37

In 2005, AAP did not recommend breastfeeding as a means to reduce the risk of SIDS because available evidence was mixed, and studies at the time were poorly controlled.38 Since that time, case-control meta-analyses have shed additional light on the association between SIDS and feeding method.35,37

The protective effect exists for any amount of breastfeeding and is stronger for exclusive breastfeeding, suggesting a protective role—not simply an association. Caution should be employed with this conclusion, however, because the studies included in the meta-analysis used univariate analysis primarily and did not control sufficiently for known confounders. In addition, the authors warn that publication bias might overestimate the association.38

Exclusive breastfeeding is likely the single greatest risk factor for hospital readmission in newborns.

Potential mechanisms of a protective role include decreased risk of infection and greater arousability from sleep in breastfed infants. Assuming a protective role, available data suggest that more than 3500 infants need to be breastfed to prevent one case of SIDS.39

Continue to: Allergic disease

 

 

Allergic disease

Asthma. There is evidence of a small protective effect of breastfeeding “ever” on asthma at 5 to 18 years of age in high-income countries (OR=0.90; 95% CI, 0.83-0.97). A family history of asthma or atopy did not affect this finding. The authors note there is some evidence of publication bias in this review, which is the largest and most comprehensive on the topic.40

With a lifetime prevalence of asthma in the United States of approximately 13.2%, this association would confer an NNT of roughly 76.41 Earlier, the literature demonstrated mixed and conflicting evidence, and some experts suggested an effect only when there is a family history of asthma or atopy.36

Eczema. For children younger than 2 years, there is low-grade- and very-low-grade-quality evidence that exclusive breastfeeding longer than 3 to 4 months is associated with a reduced risk of eczema (OR=0.74; 95% CI, 0.57-0.97).40

Previously, data suggested that this association existed only in children who had a family history of atopy.35 The protective association, however, exists regardless of family history and does not persist beyond 2 years of age. The authors noted evidence of publication bias, reverse causation, and misdiagnosis of early childhood rashes as eczema as limitations of their findings.40

Continue to: Reliable epidemiologic evidence...

 

 

Reliable epidemiologic evidence on the incidence of eczema in infants in the United States is limited, but the prevalence in the United States in children younger than 17 years is approximately 10.7% (with wide regional variation). Extrapolating these data generously, the NNT to prevent eczema in the first 2 years of life could be estimated at approximately 36.42

Allergic rhinitis. There is low-grade- and very-low-grade-quality evidence that more breastfeeding, compared to less breastfeeding, is associated with a lower risk of allergic rhinitis in children younger than 5 years (OR=0.79; 95% CI, 0.63-0.98). The association exists regardless of family history and disappears after 5 years of age. The differentiation of allergic rhinitis from rhinovirus infection (for which there is higher-quality evidence of a protective effect with breastfeeding) must be considered when interpreting these data.40

Reliable epidemiologic evidence on allergic rhinitis in children younger than 5 years is lacking, and incidence varies by region. A rough estimate, using data from 6- and 7-year-olds, indicates an NNT of 54 to 70.43

Food allergy. There is no evidence to suggest an association between breastfeeding and food allergy, either as protective or as a risk factor, and studies are limited.40 Interestingly, as data accumulate associating early exposure to foods with protection, some authors have proposed reexamining the recommendation from WHO and US health organizations for exclusive breastfeeding for the first 6 months of life.7,44

Continue to: Dental health

 

 

Dental health

Dental caries. There is consistent evidence that breastfeeding beyond 12 months of age is associated with the development of dental caries of deciduous teeth to 6 years of age (OR=2.90; 95% CI, 2.33-3.60). Many of the studies that showed this association did not control for the introduction of sugary foods and drinks, and there was a trend toward publication bias showing the association.45

Dental malocclusion. There is consistent evidence for approximately a two-thirds reduction in malocclusions in deciduous teeth in breastfed infants (OR=0.32; 95% CI, 0.25-0.40). Although the large majority of these data come from low-income and middle-income countries, the incidence of malocclusion is not thought to be associated with socioeconomic status, as so many other breastfeeding outcomes are.46

Childhood leukemia

In the largest meta-analysis available, a statistically significant inverse relationship between any breastfeeding for >6 months and childhood leukemia is evident in developed countries (OR=0.84; 95% CI, 0.78-0.91), although significant heterogeneity among studies and lack of control for confounding variables are significant limitations. In particular, an association has been demonstrated with acute lymphoblastic leukemia (ALL) but not with acute myelogenous leukemia.47 Given the rarity of childhood ALL, approximately 12,500 infants would need to be breastfed to prevent one case.48

Continue to: Long-term outcomes

 

 

Long-term outcomes

Cognitive development. Several studies conducted in developed countries have linked breastfeeding to positive cognitive outcomes in children, including higher intelligence quotient (IQ).35,49-52

These effects are conflicting, however, in studies that include sibling analysis and ones that control for maternal IQ.8,35,43,52-54 In the 2013 WHO meta-analysis, breastfeeding was associated with an increase of 2.2 points on normalized testing when only high-quality studies were included.51 A 2015 meta-analysis identified 4 high-quality studies with a large sample size and recall time <3 years, which demonstrated a mean difference of 1.76 points in IQ (95% CI, 0.25-3.26) in childhood and adolescence.52 Although statistically significant, this modest increase is of questionable clinical benefit and of unknown duration.

 

Obesity. The relationship between breastfeeding and obesity later in life is debatable. A large, systematic 2014 review of 15 cohort and 10 cross-sectional studies found a significantly reduced risk of childhood obesity among children who were breastfed (adjusted OR=0.78; 95% CI, 0.74-0.81).55 However, the review included studies that controlled for different confounders, and smaller effects were found in studies in which more confounders were taken into account.

Available data suggest that more than 3500 infants need to be breastfed to prevent one case of SIDS.

The 2013 WHO meta-analysis found a small (approximately 10%) reduction in the prevalence of overweight or obese children, but cautioned that residual confounding and publication bias were likely.51 At 6.5 and 11.5 years of follow-up, PROBIT failed to demonstrate a protective effect for exclusively or “ever” breastfed infants.56 Sibling analysis similarly fails to demonstrate a statistically significant relationship.8

Continue to: A 2015 meta-analysis of 23 high-quality studies...

 

 

A 2015 meta-analysis of 23 high-quality studies with a sample size >1500 children and controlled for important confounders showed a pooled reduction in the prevalence of overweight or obesity of 13% (95% CI, 6-19).57 The protection in this meta-analysis showed a dilution of the effect as the participants aged and an inverse relationship of the effect with sample size.

Breastfeeding is, therefore, unlikely to play a significant, if any, role in combatting the obesity epidemic.

Hypertension. A meta-analysis of high-quality trials demonstrates a <1 mm Hg reduction in systolic blood pressure and no significant difference in diastolic pressure in breastfed infants.57 Similarly, no significant effect of breastfeeding on blood pressure has been demonstrated in trials of preterm infants.51

Type 2 diabetes. Available data are limited and heterogeneous for the association between breastfeeding and later development of type 2 diabetes. Only 2 high-quality trials were identified in the 2013 WHO meta-analysis, and their results conflict.51 A 2015 meta-analysis identified only 3 high-quality studies, without a statistically significant relationship.57

Dyslipidemia. Although earlier data suggested an association between breastfeeding and reduced cholesterol levels later in life, the 2013 WHO meta-analysis and a 2015 meta-analysis concluded that no association exists. The limited data available for preterm infants conflict.51,57

Growth. There is no evidence that feeding method has a short- or long-term effect on weight gain or length gain in preterm or term infants.35,36,58

Death. No clear association has been found between mortality and breastfeeding status in developed countries, except for the association with SIDS.35

Continue to: What issues frame and guide counseling on breastfeeding?

 

 

What issues frame and guide counseling on breastfeeding?

There is that “problem” with the evidence. The evidence for infant breastfeeding status and its association with health outcomes faces significant limitations; the great majority of those limitations tend to overestimate the benefits of breastfeeding. Nearly all evidence is based on observational studies, in which causality cannot be determined and self-selection bias, recall bias, and residual confounding limit the value or strength of the findings.

The use of pacifiers before last sleep is more protective against SIDS than breastfeeding.

Breastfeeding rates are strongly socially patterned alongside socioeconomic status, race, and education level, all of which are simultaneously strongly tied to short- and long-term health outcomes.6 Other factors limiting the strength of the data set include varying definitions of infant feeding practices in different studies, varying definitions of outcomes and diseases, reverse causation, and evidence of publication bias in many meta-analyses. Given these shortcomings, the NNTs in this article probably represent a best-case scenario for breastfeeding outcomes for infants in the United States (TABLE 118,22-24,28,36,39-43,47,48).

Breastfeeding NNT to achieve short-term infant health varies widely

Data need to be put into context. The NNTs for many breastfeeding outcomes (TABLE) compare favorably with other recommended interventions, particularly for other preventive care measures. Two examples: 81 mg/d aspirin for a 50-year-old man has an NNT of 35 to 45 for preventing nonfatal myocardial infarction, and the number needed to invite to screen with mammography to prevent one breast cancer death for a 50-year-old woman is 1339.59,60

In both of these examples, >95% of patients will not benefit from the intervention, yet these preventive measures are routinely recommended and have a significant impact at the public health level. Notably, these outcomes are more serious than most breastfeeding outcomes; have a longer-lasting effect, better-quality data, and better data for potential harms; are causally linked to the intervention; and require much less effort and commitment of time than breastfeeding.

The question must be reckoned with: Can advocacy be harmful?

In recent years, a growing number of concerns have been raised about:

  • the potential harms of breastfeeding advocacy
  • exaggeration of the benefits of breastfeeding
  • promotion of breastfeeding at the expense of evidence-based medicine.

The “Ten Steps to Successful Breastfeeding” program of the Baby-friendly Hospital Initiative (BFHI; launched by UNICEF and WHO) has come under scrutiny because of an increasing number of reports of sudden unexpected postnatal collapse; fall injuries; modeling and encouragement of unsafe sleep practices; an overly rigid resistance to the use of formula supplementation; and the ban on pacifier use.61,62 The BFHI, promoted by the Centers for Disease Control and Prevention, is increasingly being adopted by hospitals with the expressed goal of increasing the breastfeeding rate from birth to discharge.

Continue to: Some of the "Ten Steps"...

 

 

Some of the “Ten Steps,” such as the call for skin-to-skin care and 24-hour rooming-in, have well-established benefit yet, when performed without supervision, can have the rare but serious unintended consequences of sudden unexpected postnatal collapse (the incidence of which may be higher than that of SIDS) and unsafe sleeping practices.62,63

Furthermore, despite evidence that early formula supplementation, when medically necessary, does not adversely impact the breastfeeding rate, the “Ten Steps” program advises that giving formula before breast milk comes in might “lead to failure to breastfeed.”33,34,61,63

Similarly, the ban on pacifiers is contrary to available evidence. The use of pacifiers before last sleep is more protective against SIDS than breastfeeding (NNT=2733), and there is evidence at one hospital that BFHI-inspired pacifier restriction is associated with a decrease in the rate of breastfeeding.64,65

Other harms of advocacy are even more poorly studied. Most of the evidence for harm comes from the psychology and social science literature—not the medical literature, perhaps because the prevailing opinion in the medical community is that breastfeeding has overwhelming evidence for benefit. In fact, in the USPSTF’s 2008 recommendation, the evidence review of breastfeeding promotion practices in primary care did not identify a single study that measured harm; in the 2016 update of that recommendation, only 2 such studies were identified.15,66

The literature that does investigate harm consistently finds that women who have difficulty breastfeeding or choose formula feeding report feelings of inadequacy, guilt, loss of agency, anxiety, and physical pain during breastfeeding that interferes with 1) their ability to bond or otherwise care for their infant and 2) competing work obligations.11-13,67-69 Given the lack of attention paid to these variables in the medical literature, it is the individual mother who is best positioned to weigh these factors against the benefits of breastfeeding.

Continue to: Shared decision-making is best—for mother and baby

 

 

Shared decision-making is best—for mother and baby

Breastfeeding might prevent certain infections in as many as 50% of infants, but a mother unable to breastfeed can take solace in the fact that >95% of breastfed infants will not realize any benefit from the preventive potential of breastfeeding in regard to hospitalization or allergic disease, and >99% will not realize benefit from either the prevention of SIDS or ALL, or from improvement in long-term health measures (except for, perhaps, a slightly higher IQ). The “breast is best” mantra is likely true at a public-health level; for the individual mother–infant dyad, however, where there is a need to balance personal, social, family, and financial factors, that mantra is an oversimplification.

The "breast is best" mantra is likely true at a public- health level; for the individual mother-infant dyad, however, that mantra is oversimplified.

Regrettably, there is a paucity of data on the risks of breastfeeding promotion—an area that deserves more study. Balancing the abundant, but often limited-quality, data on the benefits of breastfeeding and the sheer lack of data regarding the risks of advocacy represents a clinical and an ethical challenge for physicians. It is a challenge that can only be resolved through individualization of care and shared decision-making, in which the physician is expert on the benefits of breastfeeding, and the mother is expert on the personal circumstances to be weighed against those benefits.

CORRESPONDENCE
Joseph Lane Wilson, MD, ECU Brody School of Medicine, Department of Family Medicine, 101 Heart Drive, Greenville, NC 27834; [email protected].

The benefits of breastfeeding for infants have long been touted as numerous and supported by overwhelming evidence. The World Health Organization (WHO), American College of Obstetricians and Gynecologists, American Academy of Pediatrics (AAP), and American Academy of Family Physicians all strongly recommend exclusive breastfeeding for the first 6 months of life, citing numerous health benefits for child and mother. These groups recommend that some breastfeeding be continued through the first 12 months of life, or longer, as desired (the WHO extends the recommendation to 2 years).1-4 In 2000, the Surgeon General of the United States released a strategic plan to increase rates of breastfeeding,5 setting goals (by 2010) of:

  • 75% of mothers leaving the hospital breastfeeding
  • 50% of babies breastfeeding at 6 months
  • 25% of babies breastfeeding at 1 year.

Massive public health campaigns citing data for the many benefits of breastfeeding have been launched with the goal of increasing the breastfeeding rate. In 2014, statistics offered a testament to the success of these campaigns6:

  • 82.5% of infants had been breastfed “ever”
  • 55.3% were breastfed “some”
  • 24.9% were breastfed exclusively through 6 months of age
  • 33.7% were breastfed “some” at 12 months.

Breastfeeding advocacy has become clouded

In recent years, an increasing number of researchers, physicians, and authors have begun to question whether, in the United States, the benefits of breastfeeding children are exaggerated and the emphasis on breastfeeding might be leading to feelings of inadequacy, guilt, and anxiety among mothers.7-13 In 2016, the US Preventive Services Task Force (USPSTF) amended its recommendation to “promote and support breastfeeding” to simply “support breastfeeding”—a change that created substantial debate and prompted the Task Force to clarify its stance in changing the language: In its response to public comment, the USPSTF said that its position regarding promotion had not changed, but the language in the original statement had been revised to “ensure that the autonomy of women is respected.” 2,14-16

In contrast, others suggest counseling women on the risks of formula feeding rather than on the benefits of breastfeeding, citing substantial health outcome distinctions.17 Indeed, wide-ranging conclusions have been drawn from the same data on the topic, potentially creating uncertainty for physicians on how best to counsel women on their choice of how to feed their infant.

An increasing number of researchers and physicians have begun to question whether the benefits of breastfeeding are exaggerated.

In this article, we address this uncertainty by utilizing the most recent and comprehensive data to examine infant health outcomes. When possible, the number needed to treat (NNT) for a given outcome has been calculated or approximated, allowing the reader to estimate the likelihood of benefit for an individual mother–infant dyad. Exercise caution when interpreting the NNT, however: The numbers suggest causality that cannot be definitively established using the observational data on which those numbers are based.

Continue to: Infectious disease

 

 

Infectious disease

Acute otitis media. Exclusive breastfeeding for 6 months is associated with a 43% reduction in the risk of acute otitis media (AOM) by 2 years of age (odds ratio [OR]=0.57; 95% confidence interval [CI], 0.44-0.75). Beyond 2 years of age, or when comparing “ever” and “never” breastfeeding, the effect disappears. All studies in this meta-analysis had serious limitations.18

Nearly half of children will have at least one case of AOM by one year of age; 80%, by 2 years.19,20 Since the introduction of the heptavalent pneumococcal conjugate vaccine, the rate of AOM at 2 years has fallen by as much as 20%.21 Assuming an incidence of 60% to 80% of AOM by 2 years, only 2 or 3 infants need to be exclusively breastfed for 6 months to prevent a single case of AOM.18 Prevention of AOM through breastfeeding may be related to head position during feeding, antibacterial effects of breast milk, protective oral microbiome in the breastfed infant pharynx, and/or prevention of primary viral upper respiratory infection (URI), which nearly always precedes AOM.18,19

Upper and lower respiratory tract infections. Infants who are exclusively breastfed for 4 months and partially breastfed after 4 months have a lower risk of URI (OR=0.65; 95% CI, 0.51-0.83) and of lower respiratory tract infection (LRTI; OR=0.50; 95% CI, 0.32-0.72).22

The effect is stronger for URI among infants exclusively breastfed for at least 6 months (OR=0.37; 95% CI, 0.18-0.74), but is no longer significant by that time for LRTI (OR=0.33; 95% CI, 0.08-1.40). Importantly, AOM was included in the URI group, and, as previously discussed, AOM has independently been shown to have an inverse relationship with breastfeeding duration.

At 7 to 12 months of age, no association was seen between breastfeeding and the incidence of URI. Curiously, an association with LRTI was again detected for infants breastfed exclusively for 4 months and partially thereafter, but was not detected with exclusive breastfeeding for at least 6 months (OR=0.46; 95% CI, 0.31-0.69). In this study, in the first 6 months of life, 40% of infants had a URI and 8% had an LRTI. The findings in this cohort suggest an NNT of 6 or 7 for prevention of URI and an NNT of 25 for prevention of LRTI in the first 6 months of life.22

Continue to: Children younger than 2 years are...

 

 

Children younger than 2 years are estimated to have approximately 6 bouts of the common cold a year, and essentially 100% have at least one bout—perhaps lowering the NNT for URI if applied widely. However, these data are not divided into 6-month intervals, making accurate extrapolation difficult.23

Gastrointestinal infection. The rate of diarrheal illness in the first year of life is lower in infants who are exclusively breastfed for at least 4 months and partially breastfed after.

Both the Promotion of Breastfeeding Intervention Trial (PROBIT; a clinical trial in which infants were randomized to a breastfeeding education intervention or standard care) and a 2010 prospective cohort study in the Netherlands of more than 3400 infants found a reduction in the risk of one or more gastrointestinal (GI) infections at a similar rate.22,24

  • In PROBIT, 9.1% of infants in the intervention group, compared to 13.2% in the standard care group (OR=0.60; 95% CI, 0.40-0.91), had one or more GI infections at 12 months of age.24
  • In the 2010 Netherlands cohort, 8% of infants had a GI infection by 6 months of age. Infants breastfed exclusively for at least 4 or 6 months had a decreased risk for GI infection (respectively: adjusted OR=0.41; 95% CI, 0.26-0.64 and adjusted OR=0.46; 95% CI, 0.14-1.59). No such association was found for any feeding group 7 to 12 months of age.22

These studies are notable for the low incidence of GI infection, which is frequently cited as 1.3 to 2.3 episodes per child per year in children younger than 3 years in the United States.25 However, that high incidence has likely declined significantly since the introduction of rotavirus vaccine in 2006. In the years following the introduction of the vaccine, infant visits for gastroenteritis decreased by >90% in all care settings in the South, Northeast, and Midwest regions of the United States and by 53% to 63% in the West region.26 Recent accurate epidemiologic information, in an era of significantly higher vaccination rates, is lacking.

Assuming the low incidence of GI infection reported in PROBIT and the Netherlands trials, about 25 to 30 infants need to be exclusively breastfed for 4 to 6 months to prevent a single GI infection during the first 6 to 12 months of life.22,24 Assuming a 60% incidence by age 12 months before introduction of the rotavirus vaccine, the NNT would be approximately 4.24 The true number is likely somewhere between those 2 NNTs.

Continue to: Hospitalization

 

 

Hospitalization

Risk of infection is decreased. A large cohort study in Scotland, involving more than 500,000 children, found an association between exclusive breastfeeding for 6 to 8 weeks and decreased risk of hospitalization within the first 6 months of life. Formula-fed and mixed-fed infants had an increased hazard ratio (HR) for hospitalization for common childhood illness (HR=1.40; 95% CI, 1.35-1.45 for formula-fed infants and HR=1.18; 95% CI, 1.11-1.25 for mixed-fed infants).27 The study also found increased rates of hospitalization for conditions for which other meta-analyses have failed to show a protective effect from breastfeeding—leading to suspicion of residual confounding in the study. Another United Kingdom cohort demonstrated lower rates of hospitalization for GI infection (NNT=171) and LRTI (NNT=115) among exclusively breastfed infants by 8 months of age.28

Risk of neonatal readmission is increased. Late preterm infants who are exclusively breastfed are nearly twice as likely to be hospitalized as breastfed term or non-breastfed preterm infants, primarily due to dehydration, failure to thrive, weight loss, and hyperbilirubinemia. In fact, exclusive breastfeeding at discharge from the hospital is likely the single greatest risk factor for hospital readmission in newborns.29,30 Term infants who are exclusively breastfed are more likely to be hospitalized compared to formula-fed or mixed-fed infants, due to hyperbilirubinemia, dehydration, hypernatremia, and weight loss (number needed to harm (NNH)=71).30-32 For weight loss >10% of birth weight with or without hospitalization, the NNH for breastfed infants is 13.32

 

Many of these hospitalizations and events could be avoided with appropriate monitoring and medically indicated supplementation; the likelihood of long-term harm is low. Formula supplementation is often avoided if possible in hospitals to promote exclusive breastfeeding; however, several small randomized clinical trials have demonstrated that limited formula supplementation in breastfed infants does not affect the breastfeeding continuation rate at 3 and 6 months, and, therefore, might be a way to decrease infant rehospitalization.33,34

Necrotizing enterocolitis

Exclusive breastfeeding for 6 months is associated with a 43% reduction in the risk of acute otitis media by 2 years of age.

In preterm infants, breastfeeding has been associated with a lower rate of necrotizing enterocolitis. In the 2007 Agency for Healthcare Research and Quality report, the association was found to be only marginally statistically significant, and the authors warned that, first, evidence is old and heterogeneous and, second, present preterm formula is much different than the formula used in earlier studies of preterm infant nutrition and necrotizing enterocolitis.35 A 2012 Cochrane review included newer studies in its analysis but reached the same conclusion on the quality and heterogeneity of available evidence, with a NNT of 25.36

Continue to: Sudden infant death syndrome

 

 

Sudden infant death syndrome

There is a statistically significant association between sudden infant death syndrome (SIDS) and feeding method. Infants whose cause of death is SIDS are approximately one half as likely to have been breastfed as matched controls.35,37

In 2005, AAP did not recommend breastfeeding as a means to reduce the risk of SIDS because available evidence was mixed, and studies at the time were poorly controlled.38 Since that time, case-control meta-analyses have shed additional light on the association between SIDS and feeding method.35,37

The protective effect exists for any amount of breastfeeding and is stronger for exclusive breastfeeding, suggesting a protective role—not simply an association. Caution should be employed with this conclusion, however, because the studies included in the meta-analysis used univariate analysis primarily and did not control sufficiently for known confounders. In addition, the authors warn that publication bias might overestimate the association.38

Exclusive breastfeeding is likely the single greatest risk factor for hospital readmission in newborns.

Potential mechanisms of a protective role include decreased risk of infection and greater arousability from sleep in breastfed infants. Assuming a protective role, available data suggest that more than 3500 infants need to be breastfed to prevent one case of SIDS.39

Continue to: Allergic disease

 

 

Allergic disease

Asthma. There is evidence of a small protective effect of breastfeeding “ever” on asthma at 5 to 18 years of age in high-income countries (OR=0.90; 95% CI, 0.83-0.97). A family history of asthma or atopy did not affect this finding. The authors note there is some evidence of publication bias in this review, which is the largest and most comprehensive on the topic.40

With a lifetime prevalence of asthma in the United States of approximately 13.2%, this association would confer an NNT of roughly 76.41 Earlier, the literature demonstrated mixed and conflicting evidence, and some experts suggested an effect only when there is a family history of asthma or atopy.36

Eczema. For children younger than 2 years, there is low-grade- and very-low-grade-quality evidence that exclusive breastfeeding longer than 3 to 4 months is associated with a reduced risk of eczema (OR=0.74; 95% CI, 0.57-0.97).40

Previously, data suggested that this association existed only in children who had a family history of atopy.35 The protective association, however, exists regardless of family history and does not persist beyond 2 years of age. The authors noted evidence of publication bias, reverse causation, and misdiagnosis of early childhood rashes as eczema as limitations of their findings.40

Continue to: Reliable epidemiologic evidence...

 

 

Reliable epidemiologic evidence on the incidence of eczema in infants in the United States is limited, but the prevalence in the United States in children younger than 17 years is approximately 10.7% (with wide regional variation). Extrapolating these data generously, the NNT to prevent eczema in the first 2 years of life could be estimated at approximately 36.42

Allergic rhinitis. There is low-grade- and very-low-grade-quality evidence that more breastfeeding, compared to less breastfeeding, is associated with a lower risk of allergic rhinitis in children younger than 5 years (OR=0.79; 95% CI, 0.63-0.98). The association exists regardless of family history and disappears after 5 years of age. The differentiation of allergic rhinitis from rhinovirus infection (for which there is higher-quality evidence of a protective effect with breastfeeding) must be considered when interpreting these data.40

Reliable epidemiologic evidence on allergic rhinitis in children younger than 5 years is lacking, and incidence varies by region. A rough estimate, using data from 6- and 7-year-olds, indicates an NNT of 54 to 70.43

Food allergy. There is no evidence to suggest an association between breastfeeding and food allergy, either as protective or as a risk factor, and studies are limited.40 Interestingly, as data accumulate associating early exposure to foods with protection, some authors have proposed reexamining the recommendation from WHO and US health organizations for exclusive breastfeeding for the first 6 months of life.7,44

Continue to: Dental health

 

 

Dental health

Dental caries. There is consistent evidence that breastfeeding beyond 12 months of age is associated with the development of dental caries of deciduous teeth to 6 years of age (OR=2.90; 95% CI, 2.33-3.60). Many of the studies that showed this association did not control for the introduction of sugary foods and drinks, and there was a trend toward publication bias showing the association.45

Dental malocclusion. There is consistent evidence for approximately a two-thirds reduction in malocclusions in deciduous teeth in breastfed infants (OR=0.32; 95% CI, 0.25-0.40). Although the large majority of these data come from low-income and middle-income countries, the incidence of malocclusion is not thought to be associated with socioeconomic status, as so many other breastfeeding outcomes are.46

Childhood leukemia

In the largest meta-analysis available, a statistically significant inverse relationship between any breastfeeding for >6 months and childhood leukemia is evident in developed countries (OR=0.84; 95% CI, 0.78-0.91), although significant heterogeneity among studies and lack of control for confounding variables are significant limitations. In particular, an association has been demonstrated with acute lymphoblastic leukemia (ALL) but not with acute myelogenous leukemia.47 Given the rarity of childhood ALL, approximately 12,500 infants would need to be breastfed to prevent one case.48

Continue to: Long-term outcomes

 

 

Long-term outcomes

Cognitive development. Several studies conducted in developed countries have linked breastfeeding to positive cognitive outcomes in children, including higher intelligence quotient (IQ).35,49-52

These effects are conflicting, however, in studies that include sibling analysis and ones that control for maternal IQ.8,35,43,52-54 In the 2013 WHO meta-analysis, breastfeeding was associated with an increase of 2.2 points on normalized testing when only high-quality studies were included.51 A 2015 meta-analysis identified 4 high-quality studies with a large sample size and recall time <3 years, which demonstrated a mean difference of 1.76 points in IQ (95% CI, 0.25-3.26) in childhood and adolescence.52 Although statistically significant, this modest increase is of questionable clinical benefit and of unknown duration.

 

Obesity. The relationship between breastfeeding and obesity later in life is debatable. A large, systematic 2014 review of 15 cohort and 10 cross-sectional studies found a significantly reduced risk of childhood obesity among children who were breastfed (adjusted OR=0.78; 95% CI, 0.74-0.81).55 However, the review included studies that controlled for different confounders, and smaller effects were found in studies in which more confounders were taken into account.

Available data suggest that more than 3500 infants need to be breastfed to prevent one case of SIDS.

The 2013 WHO meta-analysis found a small (approximately 10%) reduction in the prevalence of overweight or obese children, but cautioned that residual confounding and publication bias were likely.51 At 6.5 and 11.5 years of follow-up, PROBIT failed to demonstrate a protective effect for exclusively or “ever” breastfed infants.56 Sibling analysis similarly fails to demonstrate a statistically significant relationship.8

Continue to: A 2015 meta-analysis of 23 high-quality studies...

 

 

A 2015 meta-analysis of 23 high-quality studies with a sample size >1500 children and controlled for important confounders showed a pooled reduction in the prevalence of overweight or obesity of 13% (95% CI, 6-19).57 The protection in this meta-analysis showed a dilution of the effect as the participants aged and an inverse relationship of the effect with sample size.

Breastfeeding is, therefore, unlikely to play a significant, if any, role in combatting the obesity epidemic.

Hypertension. A meta-analysis of high-quality trials demonstrates a <1 mm Hg reduction in systolic blood pressure and no significant difference in diastolic pressure in breastfed infants.57 Similarly, no significant effect of breastfeeding on blood pressure has been demonstrated in trials of preterm infants.51

Type 2 diabetes. Available data are limited and heterogeneous for the association between breastfeeding and later development of type 2 diabetes. Only 2 high-quality trials were identified in the 2013 WHO meta-analysis, and their results conflict.51 A 2015 meta-analysis identified only 3 high-quality studies, without a statistically significant relationship.57

Dyslipidemia. Although earlier data suggested an association between breastfeeding and reduced cholesterol levels later in life, the 2013 WHO meta-analysis and a 2015 meta-analysis concluded that no association exists. The limited data available for preterm infants conflict.51,57

Growth. There is no evidence that feeding method has a short- or long-term effect on weight gain or length gain in preterm or term infants.35,36,58

Death. No clear association has been found between mortality and breastfeeding status in developed countries, except for the association with SIDS.35

Continue to: What issues frame and guide counseling on breastfeeding?

 

 

What issues frame and guide counseling on breastfeeding?

There is that “problem” with the evidence. The evidence for infant breastfeeding status and its association with health outcomes faces significant limitations; the great majority of those limitations tend to overestimate the benefits of breastfeeding. Nearly all evidence is based on observational studies, in which causality cannot be determined and self-selection bias, recall bias, and residual confounding limit the value or strength of the findings.

The use of pacifiers before last sleep is more protective against SIDS than breastfeeding.

Breastfeeding rates are strongly socially patterned alongside socioeconomic status, race, and education level, all of which are simultaneously strongly tied to short- and long-term health outcomes.6 Other factors limiting the strength of the data set include varying definitions of infant feeding practices in different studies, varying definitions of outcomes and diseases, reverse causation, and evidence of publication bias in many meta-analyses. Given these shortcomings, the NNTs in this article probably represent a best-case scenario for breastfeeding outcomes for infants in the United States (TABLE 118,22-24,28,36,39-43,47,48).

Breastfeeding NNT to achieve short-term infant health varies widely

Data need to be put into context. The NNTs for many breastfeeding outcomes (TABLE) compare favorably with other recommended interventions, particularly for other preventive care measures. Two examples: 81 mg/d aspirin for a 50-year-old man has an NNT of 35 to 45 for preventing nonfatal myocardial infarction, and the number needed to invite to screen with mammography to prevent one breast cancer death for a 50-year-old woman is 1339.59,60

In both of these examples, >95% of patients will not benefit from the intervention, yet these preventive measures are routinely recommended and have a significant impact at the public health level. Notably, these outcomes are more serious than most breastfeeding outcomes; have a longer-lasting effect, better-quality data, and better data for potential harms; are causally linked to the intervention; and require much less effort and commitment of time than breastfeeding.

The question must be reckoned with: Can advocacy be harmful?

In recent years, a growing number of concerns have been raised about:

  • the potential harms of breastfeeding advocacy
  • exaggeration of the benefits of breastfeeding
  • promotion of breastfeeding at the expense of evidence-based medicine.

The “Ten Steps to Successful Breastfeeding” program of the Baby-friendly Hospital Initiative (BFHI; launched by UNICEF and WHO) has come under scrutiny because of an increasing number of reports of sudden unexpected postnatal collapse; fall injuries; modeling and encouragement of unsafe sleep practices; an overly rigid resistance to the use of formula supplementation; and the ban on pacifier use.61,62 The BFHI, promoted by the Centers for Disease Control and Prevention, is increasingly being adopted by hospitals with the expressed goal of increasing the breastfeeding rate from birth to discharge.

Continue to: Some of the "Ten Steps"...

 

 

Some of the “Ten Steps,” such as the call for skin-to-skin care and 24-hour rooming-in, have well-established benefit yet, when performed without supervision, can have the rare but serious unintended consequences of sudden unexpected postnatal collapse (the incidence of which may be higher than that of SIDS) and unsafe sleeping practices.62,63

Furthermore, despite evidence that early formula supplementation, when medically necessary, does not adversely impact the breastfeeding rate, the “Ten Steps” program advises that giving formula before breast milk comes in might “lead to failure to breastfeed.”33,34,61,63

Similarly, the ban on pacifiers is contrary to available evidence. The use of pacifiers before last sleep is more protective against SIDS than breastfeeding (NNT=2733), and there is evidence at one hospital that BFHI-inspired pacifier restriction is associated with a decrease in the rate of breastfeeding.64,65

Other harms of advocacy are even more poorly studied. Most of the evidence for harm comes from the psychology and social science literature—not the medical literature, perhaps because the prevailing opinion in the medical community is that breastfeeding has overwhelming evidence for benefit. In fact, in the USPSTF’s 2008 recommendation, the evidence review of breastfeeding promotion practices in primary care did not identify a single study that measured harm; in the 2016 update of that recommendation, only 2 such studies were identified.15,66

The literature that does investigate harm consistently finds that women who have difficulty breastfeeding or choose formula feeding report feelings of inadequacy, guilt, loss of agency, anxiety, and physical pain during breastfeeding that interferes with 1) their ability to bond or otherwise care for their infant and 2) competing work obligations.11-13,67-69 Given the lack of attention paid to these variables in the medical literature, it is the individual mother who is best positioned to weigh these factors against the benefits of breastfeeding.

Continue to: Shared decision-making is best—for mother and baby

 

 

Shared decision-making is best—for mother and baby

Breastfeeding might prevent certain infections in as many as 50% of infants, but a mother unable to breastfeed can take solace in the fact that >95% of breastfed infants will not realize any benefit from the preventive potential of breastfeeding in regard to hospitalization or allergic disease, and >99% will not realize benefit from either the prevention of SIDS or ALL, or from improvement in long-term health measures (except for, perhaps, a slightly higher IQ). The “breast is best” mantra is likely true at a public-health level; for the individual mother–infant dyad, however, where there is a need to balance personal, social, family, and financial factors, that mantra is an oversimplification.

The "breast is best" mantra is likely true at a public- health level; for the individual mother-infant dyad, however, that mantra is oversimplified.

Regrettably, there is a paucity of data on the risks of breastfeeding promotion—an area that deserves more study. Balancing the abundant, but often limited-quality, data on the benefits of breastfeeding and the sheer lack of data regarding the risks of advocacy represents a clinical and an ethical challenge for physicians. It is a challenge that can only be resolved through individualization of care and shared decision-making, in which the physician is expert on the benefits of breastfeeding, and the mother is expert on the personal circumstances to be weighed against those benefits.

CORRESPONDENCE
Joseph Lane Wilson, MD, ECU Brody School of Medicine, Department of Family Medicine, 101 Heart Drive, Greenville, NC 27834; [email protected].

References

1. Global Strategy for Infant and Young Child Feeding. Geneva, Switzerland: World Health Organization, and New York, NY: UNICEF; 2003. Available at: www.who.int/maternal_child_adolescent/documents/9241562218/en/. Accessed April 4, 2018.

2. American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice; Breastfeeding Expert Work Group. Committee Opinion No. 658: Optimizing support for breastfeeding as part of obstetric practice. Obstet Gynecol. 2016;127:e86-e92.

3. Gartner LM, Morton J, Lawrence RA, et al; American Academy of Pediatrics Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics. 2005;115:496-506.

4. Breastfeeding (policy statement). Leawood, KS: American Academy of Family Physicians; 2007. Available at: https://www.aafp.org/about/policies/all/breastfeeding.html. Accessed April 3, 2018.

5. Office of the Surgeon General (US); Centers for Disease Control and Prevention (US); Office on Women’s Health (US). The Surgeon General’s call to action to support breastfeeding. Rockville, MD: US Department of Health and Human Services; 2011. Available at: www.surgeongeneral.gov/library/calls/breastfeeding/index.html. Updated August 12, 2014. Accessed April 4, 2018.

6. Breastfeeding: data & statistics. Atlanta, GA: Centers for Disease Control and Prevention; December 11, 2017. Available at: http://www.cdc.gov/breastfeeding/data/. Accessed May 17, 2018.

7. Fewtrell M, Wilson DC, Booth I, et al. A. Six months of exclusive breast feeding: how good is the evidence? BMJ. 2010;342:c5955.

8. Colen CG, Ramey DM. Is breast truly best? Estimating the effect of breastfeeding on long-term child wellbeing in the United States using sibling comparisons. Soc Sci Med. 2014;109:55-65.

9. Wolf J. Is Breast Best? Taking on the Breastfeeding Experts and the New High Stakes of Motherhood. New York, NY: NYU Press; 2010.

10. Tuteur A. Push Back: Guilt in the Age of Natural Parenting. New York, NY: HarperCollins Publishers; 2016.

11. Lee E. Health, morality, and infant feeding: British mothers’ experiences of formula milk use in the early weeks. Sociol Health Illn. 2007;29:1075-1090.

12. Williams K, Donaghue N, Kurz T. “Giving guilt the flick”?: an investigation of mothers’ talk about guilt in relation to infant feeding. Psychol Women Q. 2013;37:97-112.

13. Fahlquist JN, Roeser S. Ethical problems with information on infant feeding in developed countries. J Health Polit Policy Law. 2012;37:155-160.

14. U.S. Preventive Services Task Force. Final Recommendation Statement. Breastfeeding: Counseling. Available at: www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/breastfeeding-counseling. Accessed April 4, 2018.

15. US Preventive Services Task Force. Primary Care Interventions to Support Breastfeeding: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;316:1688-1693.

16. Zahn CM, Hanley LE. Concerns over USPSTF draft recommendation on breastfeeding interventions [letter]. Washington, DC: The American College of Obstetricians and Gynecologists; May 18, 2016. Available at: https://www.acog.org/-/media/Departments/Breastfeeding/Breast-Feeding-ACOG-USPSTF.pdf?dmc=1&ts=20180518T1850056558. Accessed May 22, 2018.

17. Stuebe A. The risks of not breastfeeding for mothers and infants. Rev Obstet Gynecol. 2009;2:222-231.

18. Bowatte G, Tham R, Allen KJ, et al. Breastfeeding and childhood acute otitis media: a systematic review and meta-analysis. Acta Paediatr. 2015;104:85-95.

19. Chonmaitree T, Trujillo R, Jennings K, et al. Acute otitis media and other complications of viral respiratory infection. Pediatrics. 2016;137:e20153555.

20. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis. 1989;160:83-94.

21. Grijalva CG, Poehling KA, Nuorti JP, et al. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics. 2006;118:865-873.

22. Duijts L, Jaddoe VW, Hofman A, et al. Prolonged and exclusive breastfeeding reduces the risk of infectious diseases in infancy. Pediatrics. 2010;126:e18-e25.

23. Allan GM, Arroll B. Prevention and treatment of the common cold: making sense of the evidence. CMAJ. 2014;186:190-199.

24. Kramer MS, Chalmers B, Hodnett ED, et al; PROBIT Study Group (Promotion of Breastfeeding Intervention Trial). Promotion of Breastfeeding Intervention Trial (PROBIT): a randomized trial in the Republic of Belarus. JAMA. 2001;285:413-420.

25. Dennehy PH. Acute diarrheal disease in children: epidemiology, prevention, and treatment. Infect Dis Clin North Am. 2005;19:585-602.

26. Cortese MM, Tate JE, Simonsen L, et al. Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases. Pediatric Infect Dis J. 2010;29:489-494.

27. Ajetunmobi OM, Whyte B, Chalmers J, et al. Breastfeeding is associated with reduced childhood hospitalization: evidence from a Scottish birth cohort (1997-2009). J Pediatr. 2015;166:620-625.

28. Quigley MA, Kelly YJ, Sacker A. Breastfeeding and hospitalization for diarrheal and respiratory infection in the United Kingdom Millennium Cohort Study. Pediatrics. 2007;119:e837-e842.

29. Radtke JV. The paradox of breastfeeding-associated morbidity among late preterm infants. J Obstet Gynecol Neonatal Nurs. 2011;40:9-24.

30. Escobar GJ, Gonzales VM, Armstrong M, et al. Rehospitalization for neonatal dehydration: a nested case-control study. Arch Pediatr Adolesc Med. 2002;156:155-161.

31. Salas AA, Salazar J, Burgoa CV, et al. Significant weight loss in breastfed term infants readmitted for hyperbilirubinemia. BMC Pediatr. 2009;9:82.

32. Tarcan A, Tiker F, Vatandaş NS, et al. Weight loss and hypernatremia in breast-fed babies: frequency in neonates with non-hemolytic jaundice. J Paediatr Child Health. 2005;41:484-487.

33. Flaherman VJ, Aby J, Burgos AE, et al. Effect of early limited formula on duration and exclusivity of breastfeeding in at-risk infants: an RCT. Pediatrics. 2013;131:1059-1065.

34. Straňák Z, Feyereislova S, Černá M, et al. J. Limited amount of formula may facilitate breastfeeding: randomized, controlled trial to compare standard clinical practice versus limited supplemental feeding. Denning PW, ed. PLoS One. 2016;11:e0150053.

35. Ip S, Chung M, Raman G, et al. Breastfeeding and Maternal and Infant Health Outcomes in Developed Countries. Rockville, MD: Agency for Healthcare Research and Quality (US); 2007. Evidence Reports/Technology Assessments, No. 153. Available at: www.ncbi.nlm.nih.gov/books/NBK38337/. Accessed April 3, 2018.

36. Quigley M, McGuire W. Formula versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev. 2014;(4):CD002971.

37. Hauck FR, Thompson JM, Tanabe KO, et al. Breastfeeding and reduced risk of sudden infant death syndrome: a meta-analysis. Pediatrics. 2011;128:103-110.

38. American Academy of Pediatrics Task Force on Sudden Infant Death Syndrome. The changing concept of sudden infant death syndrome: diagnostic coding shifts, controversies regarding the sleeping environment, and new variables to consider in reducing risk. Pediatrics. 2005;116:1245-1255.

39. Moon RY, Fu L. Sudden infant death syndrome: an update. Pediatr Rev. 2012;33:314-320.

40. Lodge CJ, Tan DJ, Lau MX, et al. Breastfeeding and asthma and allergies: a systematic review and meta-analysis. Acta Paediatr. 2015;104:38-53.

41. Brim SN, Rudd RA, Funk RH, et al. Asthma prevalence among US children in underrepresented minority populations: American Indian/Alaska Native, Chinese, Filipino, and Asian Indian. Pediatrics. 2008;122:e217-e222.

42. Shaw TF, Currie GP, Koudelka CW, et al. Eczema prevalence in the United States: data from the 2003 National Survey of Children’s Health. J Invest Dermatol. 2011;131:67-73.

43. Mallol J, Crane J, von Mutius E, et al. The international study of asthma and allergies in childhood (ISAAC) Phase Three: a global synthesis. Allergol Immunopathol (Madr). 2013;41:73-85.

44. Flohr C, Nagel G, Weinmayr G, et al. Lack of evidence for a protective effect of prolonged breastfeeding on childhood eczema: lessons from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two. Br J Dermatol. 2011;165:1280-1289.

45. Tham R, Bowatte G, Dharmage SC, et al. Breastfeeding and the risk of dental caries: a systematic review and meta-analysis. Acta Paediatr. 2015;104:62-84.

46. Peres KG, Cascaes AM, Nascimento GG, et al. Effect of breastfeeding on malocclusions: a systematic review and meta-analysis. Acta Paediatr. 2015;104:54-61.

47. Amitya EL, Keinan-Boker L. Breastfeeding and childhood leukemia incidence: a meta-analysis and systematic review. JAMA Pediatr. 2015;169:e151025.

48. Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. Lancet. 2013;381:1943-1955.

49. Guxens M, Mendez MA, Moltó-Puigmartí C, et al. Breastfeeding, long-chain polyunsaturated fatty acids in colostrum, and infant mental development.

2012;129:1134-1140.

51. Horta BL, Victora CG. Long-term effects of breastfeeding: a systematic review. Geneva, Switzerland: World Health Organization; 2013. Available at: http://apps.who.int/iris/bitstream/10665/79198/1/9789241505307_eng.pdf. Accessed August 16, 2016.

52. Horta BL, Loret de Mola C, Victora CG. Breastfeeding and intelligence: a systematic review and meta-analysis. Acta Paediatr. 2015;104:14-19.

53. Der G, Batty GD, Deary IJ. Effect of breast feeding on intelligence in children: prospective study, sibling pairs analysis, and meta-analysis. BMJ. 2006;333:945.

54. Sajjad A, Tharner A, Kiefte-de Jong JC, et al. Breastfeeding duration and non-verbal IQ in children. J Epidemiol Community Health 2015;69:775-781.

55. Yan J, Liu L, Zhu Y, et al. The association between breastfeeding and childhood obesity: a meta-analysis. BMC Public Health. 2014;14:1267.

56. Martin RM, Patel R, Kramer MS, et al. Effects of promoting longer-term and exclusive breastfeeding on adiposity and insulin-like growth factor-I at age 11.5 years: a randomized trial. JAMA. 2013;309:1005-1013.

57. Horta BL, Loret de Mola C, Victora CG. Long-term consequences of breastfeeding on cholesterol, obesity, systolic blood pressure, and type 2 diabetes: systematic review and meta-analysis. Acta Paediatr. 2015;104:30-37.

58. Kramer MS, Kakuma R. Optimal duration of exclusive breastfeeding. Cochrane Database of Syst Rev. 2012;15:CD003517.

59. U.S. Preventive Services Task Force. Final recommendation statement: aspirin use to prevent cardiovascular disease and colorectal cancer: preventive medication. Available at: www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/aspirin-to-prevent-cardiovascular-disease-and-cancer. Published September 2017. Accessed April 3, 2018.

60. U.S. Preventive Services Task Force. Screening for breast cancer. Available at: www.uspreventiveservicestaskforce.org/Page/SupportingDoc/breast-cancer-screening/final-evidence-summary9. Published November 2009. Accessed April 2, 2018.

61. Bass JL, Gartley T, Kleinman R. Unintended consequences of current breastfeeding initiatives. JAMA Pediatr. 2016;170:923-924.

62. Feldman-Winter L, Goldsmith JP; Committee on Fetus and Newborn; Task Force on Sudden Infant Death Syndrome. Safe sleep and skin-to-skin care in the neonatal period for healthy term newborns. Pediatrics. 2016;138:e20161889.

63. The Mother and Child Health and Education Trust. Ten steps to successful breastfeeding. Available at: www.tensteps.org. Published November 8, 2017. Accessed April 3, 2018.

64. Hauck FR, Omojokun OO, Siadaty MS. Do pacifiers reduce the risk of sudden infant death syndrome? A meta-analysis. Pediatrics. 2005;116:e716-e723.

65. Kair LR, Kenron D, Etheredge K, et al. Pacifier restriction and exclusive breastfeeding. Pediatrics. 2013;131:e1101-e1107.

66. Chung M, Raman G, Trikalinos T, et al. Interventions in primary care to promote breastfeeding: an evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:565-582.

67. Wolf JB. Is breast really best? Risk and total motherhood in the National Breastfeeding Awareness Campaign. J Health Polit Policy Law. 2007;32:595-636.

68. Marshall JL, Godfrey M, Renfrew MJ. Being a ‘good mother’: managing breastfeeding and merging identities. Soc Sci Med. 2007;65:2147-2159.

69. Kelleher CM. The physical challenges of early breastfeeding. Soc Sci Med. 2006;63:2727-2738.

References

1. Global Strategy for Infant and Young Child Feeding. Geneva, Switzerland: World Health Organization, and New York, NY: UNICEF; 2003. Available at: www.who.int/maternal_child_adolescent/documents/9241562218/en/. Accessed April 4, 2018.

2. American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice; Breastfeeding Expert Work Group. Committee Opinion No. 658: Optimizing support for breastfeeding as part of obstetric practice. Obstet Gynecol. 2016;127:e86-e92.

3. Gartner LM, Morton J, Lawrence RA, et al; American Academy of Pediatrics Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics. 2005;115:496-506.

4. Breastfeeding (policy statement). Leawood, KS: American Academy of Family Physicians; 2007. Available at: https://www.aafp.org/about/policies/all/breastfeeding.html. Accessed April 3, 2018.

5. Office of the Surgeon General (US); Centers for Disease Control and Prevention (US); Office on Women’s Health (US). The Surgeon General’s call to action to support breastfeeding. Rockville, MD: US Department of Health and Human Services; 2011. Available at: www.surgeongeneral.gov/library/calls/breastfeeding/index.html. Updated August 12, 2014. Accessed April 4, 2018.

6. Breastfeeding: data & statistics. Atlanta, GA: Centers for Disease Control and Prevention; December 11, 2017. Available at: http://www.cdc.gov/breastfeeding/data/. Accessed May 17, 2018.

7. Fewtrell M, Wilson DC, Booth I, et al. A. Six months of exclusive breast feeding: how good is the evidence? BMJ. 2010;342:c5955.

8. Colen CG, Ramey DM. Is breast truly best? Estimating the effect of breastfeeding on long-term child wellbeing in the United States using sibling comparisons. Soc Sci Med. 2014;109:55-65.

9. Wolf J. Is Breast Best? Taking on the Breastfeeding Experts and the New High Stakes of Motherhood. New York, NY: NYU Press; 2010.

10. Tuteur A. Push Back: Guilt in the Age of Natural Parenting. New York, NY: HarperCollins Publishers; 2016.

11. Lee E. Health, morality, and infant feeding: British mothers’ experiences of formula milk use in the early weeks. Sociol Health Illn. 2007;29:1075-1090.

12. Williams K, Donaghue N, Kurz T. “Giving guilt the flick”?: an investigation of mothers’ talk about guilt in relation to infant feeding. Psychol Women Q. 2013;37:97-112.

13. Fahlquist JN, Roeser S. Ethical problems with information on infant feeding in developed countries. J Health Polit Policy Law. 2012;37:155-160.

14. U.S. Preventive Services Task Force. Final Recommendation Statement. Breastfeeding: Counseling. Available at: www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/breastfeeding-counseling. Accessed April 4, 2018.

15. US Preventive Services Task Force. Primary Care Interventions to Support Breastfeeding: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;316:1688-1693.

16. Zahn CM, Hanley LE. Concerns over USPSTF draft recommendation on breastfeeding interventions [letter]. Washington, DC: The American College of Obstetricians and Gynecologists; May 18, 2016. Available at: https://www.acog.org/-/media/Departments/Breastfeeding/Breast-Feeding-ACOG-USPSTF.pdf?dmc=1&ts=20180518T1850056558. Accessed May 22, 2018.

17. Stuebe A. The risks of not breastfeeding for mothers and infants. Rev Obstet Gynecol. 2009;2:222-231.

18. Bowatte G, Tham R, Allen KJ, et al. Breastfeeding and childhood acute otitis media: a systematic review and meta-analysis. Acta Paediatr. 2015;104:85-95.

19. Chonmaitree T, Trujillo R, Jennings K, et al. Acute otitis media and other complications of viral respiratory infection. Pediatrics. 2016;137:e20153555.

20. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis. 1989;160:83-94.

21. Grijalva CG, Poehling KA, Nuorti JP, et al. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics. 2006;118:865-873.

22. Duijts L, Jaddoe VW, Hofman A, et al. Prolonged and exclusive breastfeeding reduces the risk of infectious diseases in infancy. Pediatrics. 2010;126:e18-e25.

23. Allan GM, Arroll B. Prevention and treatment of the common cold: making sense of the evidence. CMAJ. 2014;186:190-199.

24. Kramer MS, Chalmers B, Hodnett ED, et al; PROBIT Study Group (Promotion of Breastfeeding Intervention Trial). Promotion of Breastfeeding Intervention Trial (PROBIT): a randomized trial in the Republic of Belarus. JAMA. 2001;285:413-420.

25. Dennehy PH. Acute diarrheal disease in children: epidemiology, prevention, and treatment. Infect Dis Clin North Am. 2005;19:585-602.

26. Cortese MM, Tate JE, Simonsen L, et al. Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases. Pediatric Infect Dis J. 2010;29:489-494.

27. Ajetunmobi OM, Whyte B, Chalmers J, et al. Breastfeeding is associated with reduced childhood hospitalization: evidence from a Scottish birth cohort (1997-2009). J Pediatr. 2015;166:620-625.

28. Quigley MA, Kelly YJ, Sacker A. Breastfeeding and hospitalization for diarrheal and respiratory infection in the United Kingdom Millennium Cohort Study. Pediatrics. 2007;119:e837-e842.

29. Radtke JV. The paradox of breastfeeding-associated morbidity among late preterm infants. J Obstet Gynecol Neonatal Nurs. 2011;40:9-24.

30. Escobar GJ, Gonzales VM, Armstrong M, et al. Rehospitalization for neonatal dehydration: a nested case-control study. Arch Pediatr Adolesc Med. 2002;156:155-161.

31. Salas AA, Salazar J, Burgoa CV, et al. Significant weight loss in breastfed term infants readmitted for hyperbilirubinemia. BMC Pediatr. 2009;9:82.

32. Tarcan A, Tiker F, Vatandaş NS, et al. Weight loss and hypernatremia in breast-fed babies: frequency in neonates with non-hemolytic jaundice. J Paediatr Child Health. 2005;41:484-487.

33. Flaherman VJ, Aby J, Burgos AE, et al. Effect of early limited formula on duration and exclusivity of breastfeeding in at-risk infants: an RCT. Pediatrics. 2013;131:1059-1065.

34. Straňák Z, Feyereislova S, Černá M, et al. J. Limited amount of formula may facilitate breastfeeding: randomized, controlled trial to compare standard clinical practice versus limited supplemental feeding. Denning PW, ed. PLoS One. 2016;11:e0150053.

35. Ip S, Chung M, Raman G, et al. Breastfeeding and Maternal and Infant Health Outcomes in Developed Countries. Rockville, MD: Agency for Healthcare Research and Quality (US); 2007. Evidence Reports/Technology Assessments, No. 153. Available at: www.ncbi.nlm.nih.gov/books/NBK38337/. Accessed April 3, 2018.

36. Quigley M, McGuire W. Formula versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev. 2014;(4):CD002971.

37. Hauck FR, Thompson JM, Tanabe KO, et al. Breastfeeding and reduced risk of sudden infant death syndrome: a meta-analysis. Pediatrics. 2011;128:103-110.

38. American Academy of Pediatrics Task Force on Sudden Infant Death Syndrome. The changing concept of sudden infant death syndrome: diagnostic coding shifts, controversies regarding the sleeping environment, and new variables to consider in reducing risk. Pediatrics. 2005;116:1245-1255.

39. Moon RY, Fu L. Sudden infant death syndrome: an update. Pediatr Rev. 2012;33:314-320.

40. Lodge CJ, Tan DJ, Lau MX, et al. Breastfeeding and asthma and allergies: a systematic review and meta-analysis. Acta Paediatr. 2015;104:38-53.

41. Brim SN, Rudd RA, Funk RH, et al. Asthma prevalence among US children in underrepresented minority populations: American Indian/Alaska Native, Chinese, Filipino, and Asian Indian. Pediatrics. 2008;122:e217-e222.

42. Shaw TF, Currie GP, Koudelka CW, et al. Eczema prevalence in the United States: data from the 2003 National Survey of Children’s Health. J Invest Dermatol. 2011;131:67-73.

43. Mallol J, Crane J, von Mutius E, et al. The international study of asthma and allergies in childhood (ISAAC) Phase Three: a global synthesis. Allergol Immunopathol (Madr). 2013;41:73-85.

44. Flohr C, Nagel G, Weinmayr G, et al. Lack of evidence for a protective effect of prolonged breastfeeding on childhood eczema: lessons from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two. Br J Dermatol. 2011;165:1280-1289.

45. Tham R, Bowatte G, Dharmage SC, et al. Breastfeeding and the risk of dental caries: a systematic review and meta-analysis. Acta Paediatr. 2015;104:62-84.

46. Peres KG, Cascaes AM, Nascimento GG, et al. Effect of breastfeeding on malocclusions: a systematic review and meta-analysis. Acta Paediatr. 2015;104:54-61.

47. Amitya EL, Keinan-Boker L. Breastfeeding and childhood leukemia incidence: a meta-analysis and systematic review. JAMA Pediatr. 2015;169:e151025.

48. Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. Lancet. 2013;381:1943-1955.

49. Guxens M, Mendez MA, Moltó-Puigmartí C, et al. Breastfeeding, long-chain polyunsaturated fatty acids in colostrum, and infant mental development.

2012;129:1134-1140.

51. Horta BL, Victora CG. Long-term effects of breastfeeding: a systematic review. Geneva, Switzerland: World Health Organization; 2013. Available at: http://apps.who.int/iris/bitstream/10665/79198/1/9789241505307_eng.pdf. Accessed August 16, 2016.

52. Horta BL, Loret de Mola C, Victora CG. Breastfeeding and intelligence: a systematic review and meta-analysis. Acta Paediatr. 2015;104:14-19.

53. Der G, Batty GD, Deary IJ. Effect of breast feeding on intelligence in children: prospective study, sibling pairs analysis, and meta-analysis. BMJ. 2006;333:945.

54. Sajjad A, Tharner A, Kiefte-de Jong JC, et al. Breastfeeding duration and non-verbal IQ in children. J Epidemiol Community Health 2015;69:775-781.

55. Yan J, Liu L, Zhu Y, et al. The association between breastfeeding and childhood obesity: a meta-analysis. BMC Public Health. 2014;14:1267.

56. Martin RM, Patel R, Kramer MS, et al. Effects of promoting longer-term and exclusive breastfeeding on adiposity and insulin-like growth factor-I at age 11.5 years: a randomized trial. JAMA. 2013;309:1005-1013.

57. Horta BL, Loret de Mola C, Victora CG. Long-term consequences of breastfeeding on cholesterol, obesity, systolic blood pressure, and type 2 diabetes: systematic review and meta-analysis. Acta Paediatr. 2015;104:30-37.

58. Kramer MS, Kakuma R. Optimal duration of exclusive breastfeeding. Cochrane Database of Syst Rev. 2012;15:CD003517.

59. U.S. Preventive Services Task Force. Final recommendation statement: aspirin use to prevent cardiovascular disease and colorectal cancer: preventive medication. Available at: www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/aspirin-to-prevent-cardiovascular-disease-and-cancer. Published September 2017. Accessed April 3, 2018.

60. U.S. Preventive Services Task Force. Screening for breast cancer. Available at: www.uspreventiveservicestaskforce.org/Page/SupportingDoc/breast-cancer-screening/final-evidence-summary9. Published November 2009. Accessed April 2, 2018.

61. Bass JL, Gartley T, Kleinman R. Unintended consequences of current breastfeeding initiatives. JAMA Pediatr. 2016;170:923-924.

62. Feldman-Winter L, Goldsmith JP; Committee on Fetus and Newborn; Task Force on Sudden Infant Death Syndrome. Safe sleep and skin-to-skin care in the neonatal period for healthy term newborns. Pediatrics. 2016;138:e20161889.

63. The Mother and Child Health and Education Trust. Ten steps to successful breastfeeding. Available at: www.tensteps.org. Published November 8, 2017. Accessed April 3, 2018.

64. Hauck FR, Omojokun OO, Siadaty MS. Do pacifiers reduce the risk of sudden infant death syndrome? A meta-analysis. Pediatrics. 2005;116:e716-e723.

65. Kair LR, Kenron D, Etheredge K, et al. Pacifier restriction and exclusive breastfeeding. Pediatrics. 2013;131:e1101-e1107.

66. Chung M, Raman G, Trikalinos T, et al. Interventions in primary care to promote breastfeeding: an evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:565-582.

67. Wolf JB. Is breast really best? Risk and total motherhood in the National Breastfeeding Awareness Campaign. J Health Polit Policy Law. 2007;32:595-636.

68. Marshall JL, Godfrey M, Renfrew MJ. Being a ‘good mother’: managing breastfeeding and merging identities. Soc Sci Med. 2007;65:2147-2159.

69. Kelleher CM. The physical challenges of early breastfeeding. Soc Sci Med. 2006;63:2727-2738.

Issue
The Journal of Family Practice - 67(6)
Issue
The Journal of Family Practice - 67(6)
Page Number
E1-E9
Page Number
E1-E9
Publications
Publications
Topics
Article Type
Display Headline
Is the "breast is best" mantra an oversimplification?
Display Headline
Is the "breast is best" mantra an oversimplification?
Sections
Article Source

From The Journal of Family Practice | 2018;67(6):E1-E9.

Inside the Article

PRACTICE RECOMMENDATIONS

› Encourage breastfeeding for its potential to reduce the risk of acute otitis media, upper- and lower-respiratory infections, gastrointestinal infection, and dental malocclusion. A

› Promote breastfeeding for its potential to make a small difference in intelligence quotient and the incidence of overweight and obesity—but not for any other significant impact on long-term health. B

› Consider the needs and preferences of the individual when advocating breastfeeding so as to avoid potentially engendering maternal feelings of guilt and inadequacy. C

Strength of recommendation (SOR)

A Good-quality patient-oriented evidence
B Inconsistent or limited-quality patient-oriented evidence
C Consensus, usual practice, opinion, disease-oriented evidence, case series

Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
PubMed ID
29879244
Disqus Comments
Default
Use ProPublica
Article PDF Media

June 2018: Click for Credit

Article Type
Changed
Display Headline
Click for Credit: Missed dermatologic diagnoses; pain after hernia surgery; more

Here are 4 articles from the June issue of Clinician Reviews (individual articles are valid for one year from date of publication—expiration dates below):

1. Dermatology Practice Gaps: Missed Diagnoses

To take the posttest, go to: https://bit.ly/2IhaxSm
Expires February 11, 2019

2. When to Worry About Congenital Melanocytic Nevi

To take the posttest, go to: https://bit.ly/2IhMOBC
Expires March 2, 2019

3. Unscheduled Visits for Pain After Hernia Surgery Common, Costly

To take the posttest, go to: https://bit.ly/2GbfWIV
Expires February 15, 2019

4. Melanoma Incidence Increased in Older Non-Hispanic Whites

To take the posttest, go to: https://bit.ly/2wOkVzZ
Expires February 9, 2019

Issue
Clinician Reviews - 28(6)
Publications
Topics
Sections

Here are 4 articles from the June issue of Clinician Reviews (individual articles are valid for one year from date of publication—expiration dates below):

1. Dermatology Practice Gaps: Missed Diagnoses

To take the posttest, go to: https://bit.ly/2IhaxSm
Expires February 11, 2019

2. When to Worry About Congenital Melanocytic Nevi

To take the posttest, go to: https://bit.ly/2IhMOBC
Expires March 2, 2019

3. Unscheduled Visits for Pain After Hernia Surgery Common, Costly

To take the posttest, go to: https://bit.ly/2GbfWIV
Expires February 15, 2019

4. Melanoma Incidence Increased in Older Non-Hispanic Whites

To take the posttest, go to: https://bit.ly/2wOkVzZ
Expires February 9, 2019

Here are 4 articles from the June issue of Clinician Reviews (individual articles are valid for one year from date of publication—expiration dates below):

1. Dermatology Practice Gaps: Missed Diagnoses

To take the posttest, go to: https://bit.ly/2IhaxSm
Expires February 11, 2019

2. When to Worry About Congenital Melanocytic Nevi

To take the posttest, go to: https://bit.ly/2IhMOBC
Expires March 2, 2019

3. Unscheduled Visits for Pain After Hernia Surgery Common, Costly

To take the posttest, go to: https://bit.ly/2GbfWIV
Expires February 15, 2019

4. Melanoma Incidence Increased in Older Non-Hispanic Whites

To take the posttest, go to: https://bit.ly/2wOkVzZ
Expires February 9, 2019

Issue
Clinician Reviews - 28(6)
Issue
Clinician Reviews - 28(6)
Publications
Publications
Topics
Article Type
Display Headline
Click for Credit: Missed dermatologic diagnoses; pain after hernia surgery; more
Display Headline
Click for Credit: Missed dermatologic diagnoses; pain after hernia surgery; more
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Un-Gate On Date
Use ProPublica
CFC Schedule Remove Status

Don’t overlook these uses of point-of-care ultrasound

Article Type
Changed
Display Headline
Don’t overlook these uses of point-of-care ultrasound

In the article, “Point-of-care ultrasound: Coming soon to primary care?” (J Fam Pract. 2018;67:70-79), Bornemann et al outline potential uses for point-of-care ultrasound (POCUS), describing in detail its role in cardiovascular and pulmonary exams, screening for abdominal aortic aneurysms, and diagnosing deep vein thrombosis. The American Academy of Family Physicians, in the Recommended Curriculum Guidelines for Family Medicine Residents (available at: https://www.aafp.org/medical-school-residency/program-directors/curriculum.html), also discusses obstetric and gynecologic uses for POCUS, such as determining fetal presentation and distinguishing viable pregnancy from miscarriage.

In my practice, I most often use POCUS for gynecologic and pregnancy-related issues, such as to ensure proper placement of an intrauterine device (IUD) when the strings are not visible, to determine gestational age in patients with uncertain last menstrual periods, and to confirm pregnancy location when patients have risk factors for, or symptoms suggestive of, ectopic pregnancy.

The breadth of care provided in family medicine is what makes it special. We must make sure that as we expand our care with new technologies, we do not trade tried and true uses of those technologies for newer ones.

Zoey Thill, MD, MPP
Bronx, NY

Article PDF
Issue
The Journal of Family Practice - 67(6)
Publications
Topics
Page Number
336
Sections
Article PDF
Article PDF

In the article, “Point-of-care ultrasound: Coming soon to primary care?” (J Fam Pract. 2018;67:70-79), Bornemann et al outline potential uses for point-of-care ultrasound (POCUS), describing in detail its role in cardiovascular and pulmonary exams, screening for abdominal aortic aneurysms, and diagnosing deep vein thrombosis. The American Academy of Family Physicians, in the Recommended Curriculum Guidelines for Family Medicine Residents (available at: https://www.aafp.org/medical-school-residency/program-directors/curriculum.html), also discusses obstetric and gynecologic uses for POCUS, such as determining fetal presentation and distinguishing viable pregnancy from miscarriage.

In my practice, I most often use POCUS for gynecologic and pregnancy-related issues, such as to ensure proper placement of an intrauterine device (IUD) when the strings are not visible, to determine gestational age in patients with uncertain last menstrual periods, and to confirm pregnancy location when patients have risk factors for, or symptoms suggestive of, ectopic pregnancy.

The breadth of care provided in family medicine is what makes it special. We must make sure that as we expand our care with new technologies, we do not trade tried and true uses of those technologies for newer ones.

Zoey Thill, MD, MPP
Bronx, NY

In the article, “Point-of-care ultrasound: Coming soon to primary care?” (J Fam Pract. 2018;67:70-79), Bornemann et al outline potential uses for point-of-care ultrasound (POCUS), describing in detail its role in cardiovascular and pulmonary exams, screening for abdominal aortic aneurysms, and diagnosing deep vein thrombosis. The American Academy of Family Physicians, in the Recommended Curriculum Guidelines for Family Medicine Residents (available at: https://www.aafp.org/medical-school-residency/program-directors/curriculum.html), also discusses obstetric and gynecologic uses for POCUS, such as determining fetal presentation and distinguishing viable pregnancy from miscarriage.

In my practice, I most often use POCUS for gynecologic and pregnancy-related issues, such as to ensure proper placement of an intrauterine device (IUD) when the strings are not visible, to determine gestational age in patients with uncertain last menstrual periods, and to confirm pregnancy location when patients have risk factors for, or symptoms suggestive of, ectopic pregnancy.

The breadth of care provided in family medicine is what makes it special. We must make sure that as we expand our care with new technologies, we do not trade tried and true uses of those technologies for newer ones.

Zoey Thill, MD, MPP
Bronx, NY

Issue
The Journal of Family Practice - 67(6)
Issue
The Journal of Family Practice - 67(6)
Page Number
336
Page Number
336
Publications
Publications
Topics
Article Type
Display Headline
Don’t overlook these uses of point-of-care ultrasound
Display Headline
Don’t overlook these uses of point-of-care ultrasound
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
PubMed ID
29879243
Disqus Comments
Default
Use ProPublica
Article PDF Media

Restoring healing to the patient-provider conversation

Article Type
Changed
Display Headline
Restoring healing to the patient-provider conversation

This country continues to struggle with the issue of how to pay for health care. But regardless of the source of payment, primary care usually gets caught in the middle. Squeezed between volume and value, family physicians know all too well the gap that exists between what our patients need and what our training and health care system allow us to provide.

This knowledge prompted me to change how I conduct my day-to-day office visits. To routinely restore healing to the patient-provider conversation, I developed a tool called the HOPE (Healing Oriented Practices and Environments) Note. It consists of a set of questions to ask during a routine office visit that are specifically geared toward uncovering and addressing patients’ personal determinants of health and healing.

During a HOPE consultation, I seek to reframe the orientation from one that focuses only on disease treatment to one that emphasizes self-healing. Example questions include: What matters to you? What brings you joy? How is your social support? What do you eat? How is your sleep? What is your home like? Do you feel safe? How do you manage stress?

From there, I develop a personalized health promotion plan adjusted to the patient’s needs, personality, readiness, resources, and circumstances. Usually, patients benefit from additional assistance, such as health coaching and ways to measure and track progress. I have created a HOPE Note Checklist to teach students and residents about this approach, and a patient guide to help prepare patients for the visit ahead of time. (To access the guide and other free HOPE Note tools, see www.drwaynejonas.com/hope.)

Of course, these tools won’t single-handedly solve the issue of health care costs. But by practicing in a way that prioritizes what really matters to patients, we begin to take health care reform into our own hands.

Wayne B. Jonas, MD
Alexandria, Va

Article PDF
Issue
The Journal of Family Practice - 67(6)
Publications
Topics
Page Number
336
Sections
Article PDF
Article PDF

This country continues to struggle with the issue of how to pay for health care. But regardless of the source of payment, primary care usually gets caught in the middle. Squeezed between volume and value, family physicians know all too well the gap that exists between what our patients need and what our training and health care system allow us to provide.

This knowledge prompted me to change how I conduct my day-to-day office visits. To routinely restore healing to the patient-provider conversation, I developed a tool called the HOPE (Healing Oriented Practices and Environments) Note. It consists of a set of questions to ask during a routine office visit that are specifically geared toward uncovering and addressing patients’ personal determinants of health and healing.

During a HOPE consultation, I seek to reframe the orientation from one that focuses only on disease treatment to one that emphasizes self-healing. Example questions include: What matters to you? What brings you joy? How is your social support? What do you eat? How is your sleep? What is your home like? Do you feel safe? How do you manage stress?

From there, I develop a personalized health promotion plan adjusted to the patient’s needs, personality, readiness, resources, and circumstances. Usually, patients benefit from additional assistance, such as health coaching and ways to measure and track progress. I have created a HOPE Note Checklist to teach students and residents about this approach, and a patient guide to help prepare patients for the visit ahead of time. (To access the guide and other free HOPE Note tools, see www.drwaynejonas.com/hope.)

Of course, these tools won’t single-handedly solve the issue of health care costs. But by practicing in a way that prioritizes what really matters to patients, we begin to take health care reform into our own hands.

Wayne B. Jonas, MD
Alexandria, Va

This country continues to struggle with the issue of how to pay for health care. But regardless of the source of payment, primary care usually gets caught in the middle. Squeezed between volume and value, family physicians know all too well the gap that exists between what our patients need and what our training and health care system allow us to provide.

This knowledge prompted me to change how I conduct my day-to-day office visits. To routinely restore healing to the patient-provider conversation, I developed a tool called the HOPE (Healing Oriented Practices and Environments) Note. It consists of a set of questions to ask during a routine office visit that are specifically geared toward uncovering and addressing patients’ personal determinants of health and healing.

During a HOPE consultation, I seek to reframe the orientation from one that focuses only on disease treatment to one that emphasizes self-healing. Example questions include: What matters to you? What brings you joy? How is your social support? What do you eat? How is your sleep? What is your home like? Do you feel safe? How do you manage stress?

From there, I develop a personalized health promotion plan adjusted to the patient’s needs, personality, readiness, resources, and circumstances. Usually, patients benefit from additional assistance, such as health coaching and ways to measure and track progress. I have created a HOPE Note Checklist to teach students and residents about this approach, and a patient guide to help prepare patients for the visit ahead of time. (To access the guide and other free HOPE Note tools, see www.drwaynejonas.com/hope.)

Of course, these tools won’t single-handedly solve the issue of health care costs. But by practicing in a way that prioritizes what really matters to patients, we begin to take health care reform into our own hands.

Wayne B. Jonas, MD
Alexandria, Va

Issue
The Journal of Family Practice - 67(6)
Issue
The Journal of Family Practice - 67(6)
Page Number
336
Page Number
336
Publications
Publications
Topics
Article Type
Display Headline
Restoring healing to the patient-provider conversation
Display Headline
Restoring healing to the patient-provider conversation
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
PubMed ID
29879242
Disqus Comments
Default
Use ProPublica
Article PDF Media

When our biases derail the diagnosis

Article Type
Changed
Display Headline
When our biases derail the diagnosis

This month's article by Dr. Yuen and colleagues on cognitive biases and the diagnostic errors that can result is a humbling reminder of the limitations of our brains and the need for us to be ever vigilant about the accuracy of our clinical diagnoses.

According to the article, at least 8 different kinds of bias can unintentionally derail our efforts to make the correct diagnosis. In my editorial last month (J Fam Pract. 2018;67:268), I presented data showing that up to 30% of patients with a physician’s diagnosis of asthma do not, in fact, have asthma. These mistaken diagnoses are most likely due to the bias known as “diagnostic momentum,” which is the tendency of physicians to accept a diagnosis without questioning its validity.

We are also prone to anchoring. Because family physicians (FPs) are very busy and use type 1 reasoning (pattern recognition or intuitive reasoning) more frequently than type 2 reasoning (analytical thinking, which requires more time), I suspect we are most susceptible to the bias of premature closure of the diagnostic process, also called anchoring. At times we attach too much weight to preliminary findings and don’t dig deep enough into the history or physical findings to confirm or support our diagnoses.

A memorable example of my own cognitive bias was my treatment of a middle-aged woman with hyperlipidemia. I thought I was being a good doctor, treating her appropriately with a statin. Luckily for her, she saw one of my partners when I was on vacation. My partner walked into the room and immediately recognized her myxedematous face as a sign of hypothyroidism. Her thyroid stimulating hormone level was 124 mIU/L! She was cured with thyroid hormone replacement and did not need a statin at all. I had not taken the time to think through the case carefully. And I had not noticed her gradual weight gain or the changes to her face.

My partner saw the patient's myxedematous face and knew she had hypothyroidism—not hyperlipidemia.

Lulled by common diagnoses. Another difficulty for FPs and other primary care practitioners is that most of the patients we see have a common illness that is easy to diagnose. Recognizing shingles, eczema, acute appendicitis, and viral respiratory infections and managing chronic illnesses such as hypertension, diabetes, and chronic obstructive pulmonary disease (COPD) is second nature to us. But we must constantly be on the lookout for uncommon and potentially serious conditions. A classic example is not considering alpha-1 antitrypsin deficiency in a patient with COPD who does not smoke.

The bottom line: Take an extra minute or 2 to think through every diagnosis carefully—especially when one or more of the puzzle pieces do not fit together properly.

Article PDF
Author and Disclosure Information

Editor-in-Chief

John Hickner, MD, MSc

Issue
The Journal of Family Practice - 67(6)
Publications
Topics
Page Number
334
Sections
Author and Disclosure Information

Editor-in-Chief

John Hickner, MD, MSc

Author and Disclosure Information

Editor-in-Chief

John Hickner, MD, MSc

Article PDF
Article PDF

This month's article by Dr. Yuen and colleagues on cognitive biases and the diagnostic errors that can result is a humbling reminder of the limitations of our brains and the need for us to be ever vigilant about the accuracy of our clinical diagnoses.

According to the article, at least 8 different kinds of bias can unintentionally derail our efforts to make the correct diagnosis. In my editorial last month (J Fam Pract. 2018;67:268), I presented data showing that up to 30% of patients with a physician’s diagnosis of asthma do not, in fact, have asthma. These mistaken diagnoses are most likely due to the bias known as “diagnostic momentum,” which is the tendency of physicians to accept a diagnosis without questioning its validity.

We are also prone to anchoring. Because family physicians (FPs) are very busy and use type 1 reasoning (pattern recognition or intuitive reasoning) more frequently than type 2 reasoning (analytical thinking, which requires more time), I suspect we are most susceptible to the bias of premature closure of the diagnostic process, also called anchoring. At times we attach too much weight to preliminary findings and don’t dig deep enough into the history or physical findings to confirm or support our diagnoses.

A memorable example of my own cognitive bias was my treatment of a middle-aged woman with hyperlipidemia. I thought I was being a good doctor, treating her appropriately with a statin. Luckily for her, she saw one of my partners when I was on vacation. My partner walked into the room and immediately recognized her myxedematous face as a sign of hypothyroidism. Her thyroid stimulating hormone level was 124 mIU/L! She was cured with thyroid hormone replacement and did not need a statin at all. I had not taken the time to think through the case carefully. And I had not noticed her gradual weight gain or the changes to her face.

My partner saw the patient's myxedematous face and knew she had hypothyroidism—not hyperlipidemia.

Lulled by common diagnoses. Another difficulty for FPs and other primary care practitioners is that most of the patients we see have a common illness that is easy to diagnose. Recognizing shingles, eczema, acute appendicitis, and viral respiratory infections and managing chronic illnesses such as hypertension, diabetes, and chronic obstructive pulmonary disease (COPD) is second nature to us. But we must constantly be on the lookout for uncommon and potentially serious conditions. A classic example is not considering alpha-1 antitrypsin deficiency in a patient with COPD who does not smoke.

The bottom line: Take an extra minute or 2 to think through every diagnosis carefully—especially when one or more of the puzzle pieces do not fit together properly.

This month's article by Dr. Yuen and colleagues on cognitive biases and the diagnostic errors that can result is a humbling reminder of the limitations of our brains and the need for us to be ever vigilant about the accuracy of our clinical diagnoses.

According to the article, at least 8 different kinds of bias can unintentionally derail our efforts to make the correct diagnosis. In my editorial last month (J Fam Pract. 2018;67:268), I presented data showing that up to 30% of patients with a physician’s diagnosis of asthma do not, in fact, have asthma. These mistaken diagnoses are most likely due to the bias known as “diagnostic momentum,” which is the tendency of physicians to accept a diagnosis without questioning its validity.

We are also prone to anchoring. Because family physicians (FPs) are very busy and use type 1 reasoning (pattern recognition or intuitive reasoning) more frequently than type 2 reasoning (analytical thinking, which requires more time), I suspect we are most susceptible to the bias of premature closure of the diagnostic process, also called anchoring. At times we attach too much weight to preliminary findings and don’t dig deep enough into the history or physical findings to confirm or support our diagnoses.

A memorable example of my own cognitive bias was my treatment of a middle-aged woman with hyperlipidemia. I thought I was being a good doctor, treating her appropriately with a statin. Luckily for her, she saw one of my partners when I was on vacation. My partner walked into the room and immediately recognized her myxedematous face as a sign of hypothyroidism. Her thyroid stimulating hormone level was 124 mIU/L! She was cured with thyroid hormone replacement and did not need a statin at all. I had not taken the time to think through the case carefully. And I had not noticed her gradual weight gain or the changes to her face.

My partner saw the patient's myxedematous face and knew she had hypothyroidism—not hyperlipidemia.

Lulled by common diagnoses. Another difficulty for FPs and other primary care practitioners is that most of the patients we see have a common illness that is easy to diagnose. Recognizing shingles, eczema, acute appendicitis, and viral respiratory infections and managing chronic illnesses such as hypertension, diabetes, and chronic obstructive pulmonary disease (COPD) is second nature to us. But we must constantly be on the lookout for uncommon and potentially serious conditions. A classic example is not considering alpha-1 antitrypsin deficiency in a patient with COPD who does not smoke.

The bottom line: Take an extra minute or 2 to think through every diagnosis carefully—especially when one or more of the puzzle pieces do not fit together properly.

Issue
The Journal of Family Practice - 67(6)
Issue
The Journal of Family Practice - 67(6)
Page Number
334
Page Number
334
Publications
Publications
Topics
Article Type
Display Headline
When our biases derail the diagnosis
Display Headline
When our biases derail the diagnosis
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
PubMed ID
29879233
Disqus Comments
Default
Use ProPublica
Article PDF Media

Let low-risk moms eat during labor?

Article Type
Changed
Display Headline
Let low-risk moms eat during labor?

Illustrative Case

A 23-year-old nulliparous female at term with an uncomplicated pregnancy presents to labor and delivery. She reports regular contractions for the last several hours and is admitted in labor for an anticipated vaginal delivery. She has not had anything to eat or drink for the last 3 hours and says she’s hungry.

What type of diet should you order for this patient? Should you place any restrictions in the diet order?

Since the first reports of Mendelson Syndrome (aspiration during general anesthesia) in the early 1940s,2 many health care providers managing laboring women restrict their diets to clear liquids or less with little evidence to support the decision. In a recent survey of Canadian hospitals, for example, 51% of laboring women who did not receive an epidural during the active phase of labor were placed on restricted diets of only clear fluids and/or ice chips; this number rose to 83% for women who did receive an epidural.3

Dietary restrictions continue to be enforced despite the fact that only about 5% of obstetric patients require general anesthesia.1 In a study of 172,334 patients ≥18 years of age in the general population undergoing a total of 215,488 emergency or elective surgeries with general anesthesia, the risk of aspiration was 1:895 and 1:3886, respectively.4 Of the 66 patients who aspirated, 42 had no respiratory sequelae.

Similarly, Robinson et al noted that anesthesia-associated aspiration fatalities have been much lower in more recent studies than in historical ones—approximately 1 in 350,000 anesthesia events compared with 1 in 45,000 to 240,000—and are more commonly observed during intubation for emergency surgery.5

The current American College of Obstetricians and Gynecologists guidance is to restrict oral intake to clear liquids during labor for low-risk patients, with further restriction for those at increased risk for aspiration.6 The meta-analysis described here looked at the risks and benefits of a less restrictive diet during labor.

Continue to: STUDY SUMMARY

 

 

STUDY SUMMARY

Meta-analysis finds not one case of aspiration

This meta-analysis of 10 RCTs, including 3982 laboring women, analyzed the effect of food intake on labor and the risks and benefits associated with less restrictive diets for low-risk women in labor.1 Women were included in the trials if they had singleton pregnancies with cephalic presentation at the time of delivery. The women had varying cervical dilation at the time of presentation. Seven of 10 studies involved women with a gestational age ≥37 weeks, 2 studies set the gestational age threshold at 36 weeks, and one study included women with a gestational age ≥30 weeks.

Dietary restrictions during labor for women at low risk of complications/surgery are not justified based on current data.

In the intervention groups, the authors studied varying degrees of diets and/or intakes, ranging from oral carbohydrate solutions to low-fat food to a completely unrestricted diet. One study accounted for 61% of the patients in this review and compared intake of low-fat foods to ice chips, water, or sips of water until delivery. The primary outcome of the meta-analysis was duration of labor.

Results. The authors of the meta-analysis found that the patients in the intervention groups, compared with the control groups, had a shorter mean duration of labor by 16 minutes (95% confidence interval [CI], -25 to -7). Apgar scores and the rates of Cesarean delivery, operative vaginal delivery, epidural analgesia, and admission to the neonatal intensive care unit were similar in the intervention and control groups. Maternal vomiting was also similar: 37.6% in the intervention group and 36.5% in the control group (relative risk=1.00; 95% CI, 0.81-1.23). None of the 3982 patients experienced aspiration pneumonia or pneumonitis.1

WHAT’S NEW

Restricting diets during labor is outdated

For years, women’s diets have been restricted during labor without sufficient evidence to support the practice. In this systematic review and meta-analysis, Ciardulli and colleagues did not find a single case of aspiration pneumonitis—the outcome on which the rationale for restricting diets during labor is based. A 2013 Cochrane review by Singata et al also found no harm in less restrictive diets for low-risk women in labor.7 Ciardulli et al concluded that dietary restrictions for women at low risk of complications/surgery during labor are not justified based on current data.

Continue to: CAVEATS

 

 

CAVEATS

Underpowered and missing information

This meta-analysis found no occurrences of aspiration pneumonia or pneumonitis; however, it was underpowered to identify these rare complications. This is partially due to the unusual need for general anesthesia in low-risk patients, as noted earlier. Data on the total number of women who underwent general anesthesia in the current review were limited, as not every study within the meta-analysis included this information.

CHALLENGES TO IMPLEMENTATION

Stemming the cultural tide

One challenge to implementation is changing the culture of practice regarding low-risk pregnant women in labor, as well as the opinions of other health care providers and hospital policies that oppose less restrictive oral intake during labor.

ACKNOWLEDGEMENT

The PURLs Surveillance System was supported in part by Grant Number UL1RR024999 from the National Center For Research Resources, a Clinical Translational Science Award to the University of Chicago. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Research Resources or the National Institutes of Health.

Files
References

1. Ciardulli A, Saccone G, Anastasio H, et al. Less-restrictive food intake during labor in low-risk singleton pregnancies: a systematic review and meta-analysis. Obstet Gynecol. 2017;129:473-480.

2. Mendelson CL. The aspiration of stomach contents into the lungs during obstetric anesthesia. Am J Obstet Gynecol. 1946;52:191-205.

3. Chackowicz A, Spence AR, Abenhaim HA. Restrictions on oral and parenteral intake for low-risk labouring women in hospitals across Canada: a cross-sectional study. J Obstet Gynaecol Can. 2016;38:1009-1014.

4. Warner MA, Warner ME, Weber JG. Clinical significance of pulmonary aspiration during perioperative period. Anesthesiology. 1993;78:56-62.

5. Robinson M, Davidson A. Aspiration under anaesthesia: risk assessment and decision-making. Cont Educ Anaesth Crit Care Pain. 2014;14:171-175.

6. Committee on Obstetric Practice. ACOG Committee Opinion No. 441. Oral intake during labor. Obstet Gynecol. 2009;114:714. Reaffirmed 2017.

7. Singata M, Tranmer J, Gyte GM. Restricting oral fluid and food intake during labour. Cochrane Database Syst Rev. 2013;(8):CD003930.

Article PDF
Author and Disclosure Information

Eisenhower Army Medical Center, Fort Gordon, Ga (Drs. Phelps, Deavers, and Seehusen); Department of Family and Community Medicine, University of Missouri-Columbia (Dr. Stevermer) 

DEPUTY EDITOR
Anne Mounsey, MD

Department of Family Medicine, University of North Carolina, Chapel Hill

The opinions and assertions contained herein are those of the authors and are not to be construed as official or as reflecting the views of the US Army Medical Department, the Army at large, or the Department of Defense.

Issue
The Journal of Family Practice - 67(6)
Publications
Topics
Page Number
379-380
Sections
Files
Files
Author and Disclosure Information

Eisenhower Army Medical Center, Fort Gordon, Ga (Drs. Phelps, Deavers, and Seehusen); Department of Family and Community Medicine, University of Missouri-Columbia (Dr. Stevermer) 

DEPUTY EDITOR
Anne Mounsey, MD

Department of Family Medicine, University of North Carolina, Chapel Hill

The opinions and assertions contained herein are those of the authors and are not to be construed as official or as reflecting the views of the US Army Medical Department, the Army at large, or the Department of Defense.

Author and Disclosure Information

Eisenhower Army Medical Center, Fort Gordon, Ga (Drs. Phelps, Deavers, and Seehusen); Department of Family and Community Medicine, University of Missouri-Columbia (Dr. Stevermer) 

DEPUTY EDITOR
Anne Mounsey, MD

Department of Family Medicine, University of North Carolina, Chapel Hill

The opinions and assertions contained herein are those of the authors and are not to be construed as official or as reflecting the views of the US Army Medical Department, the Army at large, or the Department of Defense.

Article PDF
Article PDF

Illustrative Case

A 23-year-old nulliparous female at term with an uncomplicated pregnancy presents to labor and delivery. She reports regular contractions for the last several hours and is admitted in labor for an anticipated vaginal delivery. She has not had anything to eat or drink for the last 3 hours and says she’s hungry.

What type of diet should you order for this patient? Should you place any restrictions in the diet order?

Since the first reports of Mendelson Syndrome (aspiration during general anesthesia) in the early 1940s,2 many health care providers managing laboring women restrict their diets to clear liquids or less with little evidence to support the decision. In a recent survey of Canadian hospitals, for example, 51% of laboring women who did not receive an epidural during the active phase of labor were placed on restricted diets of only clear fluids and/or ice chips; this number rose to 83% for women who did receive an epidural.3

Dietary restrictions continue to be enforced despite the fact that only about 5% of obstetric patients require general anesthesia.1 In a study of 172,334 patients ≥18 years of age in the general population undergoing a total of 215,488 emergency or elective surgeries with general anesthesia, the risk of aspiration was 1:895 and 1:3886, respectively.4 Of the 66 patients who aspirated, 42 had no respiratory sequelae.

Similarly, Robinson et al noted that anesthesia-associated aspiration fatalities have been much lower in more recent studies than in historical ones—approximately 1 in 350,000 anesthesia events compared with 1 in 45,000 to 240,000—and are more commonly observed during intubation for emergency surgery.5

The current American College of Obstetricians and Gynecologists guidance is to restrict oral intake to clear liquids during labor for low-risk patients, with further restriction for those at increased risk for aspiration.6 The meta-analysis described here looked at the risks and benefits of a less restrictive diet during labor.

Continue to: STUDY SUMMARY

 

 

STUDY SUMMARY

Meta-analysis finds not one case of aspiration

This meta-analysis of 10 RCTs, including 3982 laboring women, analyzed the effect of food intake on labor and the risks and benefits associated with less restrictive diets for low-risk women in labor.1 Women were included in the trials if they had singleton pregnancies with cephalic presentation at the time of delivery. The women had varying cervical dilation at the time of presentation. Seven of 10 studies involved women with a gestational age ≥37 weeks, 2 studies set the gestational age threshold at 36 weeks, and one study included women with a gestational age ≥30 weeks.

Dietary restrictions during labor for women at low risk of complications/surgery are not justified based on current data.

In the intervention groups, the authors studied varying degrees of diets and/or intakes, ranging from oral carbohydrate solutions to low-fat food to a completely unrestricted diet. One study accounted for 61% of the patients in this review and compared intake of low-fat foods to ice chips, water, or sips of water until delivery. The primary outcome of the meta-analysis was duration of labor.

Results. The authors of the meta-analysis found that the patients in the intervention groups, compared with the control groups, had a shorter mean duration of labor by 16 minutes (95% confidence interval [CI], -25 to -7). Apgar scores and the rates of Cesarean delivery, operative vaginal delivery, epidural analgesia, and admission to the neonatal intensive care unit were similar in the intervention and control groups. Maternal vomiting was also similar: 37.6% in the intervention group and 36.5% in the control group (relative risk=1.00; 95% CI, 0.81-1.23). None of the 3982 patients experienced aspiration pneumonia or pneumonitis.1

WHAT’S NEW

Restricting diets during labor is outdated

For years, women’s diets have been restricted during labor without sufficient evidence to support the practice. In this systematic review and meta-analysis, Ciardulli and colleagues did not find a single case of aspiration pneumonitis—the outcome on which the rationale for restricting diets during labor is based. A 2013 Cochrane review by Singata et al also found no harm in less restrictive diets for low-risk women in labor.7 Ciardulli et al concluded that dietary restrictions for women at low risk of complications/surgery during labor are not justified based on current data.

Continue to: CAVEATS

 

 

CAVEATS

Underpowered and missing information

This meta-analysis found no occurrences of aspiration pneumonia or pneumonitis; however, it was underpowered to identify these rare complications. This is partially due to the unusual need for general anesthesia in low-risk patients, as noted earlier. Data on the total number of women who underwent general anesthesia in the current review were limited, as not every study within the meta-analysis included this information.

CHALLENGES TO IMPLEMENTATION

Stemming the cultural tide

One challenge to implementation is changing the culture of practice regarding low-risk pregnant women in labor, as well as the opinions of other health care providers and hospital policies that oppose less restrictive oral intake during labor.

ACKNOWLEDGEMENT

The PURLs Surveillance System was supported in part by Grant Number UL1RR024999 from the National Center For Research Resources, a Clinical Translational Science Award to the University of Chicago. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Research Resources or the National Institutes of Health.

Illustrative Case

A 23-year-old nulliparous female at term with an uncomplicated pregnancy presents to labor and delivery. She reports regular contractions for the last several hours and is admitted in labor for an anticipated vaginal delivery. She has not had anything to eat or drink for the last 3 hours and says she’s hungry.

What type of diet should you order for this patient? Should you place any restrictions in the diet order?

Since the first reports of Mendelson Syndrome (aspiration during general anesthesia) in the early 1940s,2 many health care providers managing laboring women restrict their diets to clear liquids or less with little evidence to support the decision. In a recent survey of Canadian hospitals, for example, 51% of laboring women who did not receive an epidural during the active phase of labor were placed on restricted diets of only clear fluids and/or ice chips; this number rose to 83% for women who did receive an epidural.3

Dietary restrictions continue to be enforced despite the fact that only about 5% of obstetric patients require general anesthesia.1 In a study of 172,334 patients ≥18 years of age in the general population undergoing a total of 215,488 emergency or elective surgeries with general anesthesia, the risk of aspiration was 1:895 and 1:3886, respectively.4 Of the 66 patients who aspirated, 42 had no respiratory sequelae.

Similarly, Robinson et al noted that anesthesia-associated aspiration fatalities have been much lower in more recent studies than in historical ones—approximately 1 in 350,000 anesthesia events compared with 1 in 45,000 to 240,000—and are more commonly observed during intubation for emergency surgery.5

The current American College of Obstetricians and Gynecologists guidance is to restrict oral intake to clear liquids during labor for low-risk patients, with further restriction for those at increased risk for aspiration.6 The meta-analysis described here looked at the risks and benefits of a less restrictive diet during labor.

Continue to: STUDY SUMMARY

 

 

STUDY SUMMARY

Meta-analysis finds not one case of aspiration

This meta-analysis of 10 RCTs, including 3982 laboring women, analyzed the effect of food intake on labor and the risks and benefits associated with less restrictive diets for low-risk women in labor.1 Women were included in the trials if they had singleton pregnancies with cephalic presentation at the time of delivery. The women had varying cervical dilation at the time of presentation. Seven of 10 studies involved women with a gestational age ≥37 weeks, 2 studies set the gestational age threshold at 36 weeks, and one study included women with a gestational age ≥30 weeks.

Dietary restrictions during labor for women at low risk of complications/surgery are not justified based on current data.

In the intervention groups, the authors studied varying degrees of diets and/or intakes, ranging from oral carbohydrate solutions to low-fat food to a completely unrestricted diet. One study accounted for 61% of the patients in this review and compared intake of low-fat foods to ice chips, water, or sips of water until delivery. The primary outcome of the meta-analysis was duration of labor.

Results. The authors of the meta-analysis found that the patients in the intervention groups, compared with the control groups, had a shorter mean duration of labor by 16 minutes (95% confidence interval [CI], -25 to -7). Apgar scores and the rates of Cesarean delivery, operative vaginal delivery, epidural analgesia, and admission to the neonatal intensive care unit were similar in the intervention and control groups. Maternal vomiting was also similar: 37.6% in the intervention group and 36.5% in the control group (relative risk=1.00; 95% CI, 0.81-1.23). None of the 3982 patients experienced aspiration pneumonia or pneumonitis.1

WHAT’S NEW

Restricting diets during labor is outdated

For years, women’s diets have been restricted during labor without sufficient evidence to support the practice. In this systematic review and meta-analysis, Ciardulli and colleagues did not find a single case of aspiration pneumonitis—the outcome on which the rationale for restricting diets during labor is based. A 2013 Cochrane review by Singata et al also found no harm in less restrictive diets for low-risk women in labor.7 Ciardulli et al concluded that dietary restrictions for women at low risk of complications/surgery during labor are not justified based on current data.

Continue to: CAVEATS

 

 

CAVEATS

Underpowered and missing information

This meta-analysis found no occurrences of aspiration pneumonia or pneumonitis; however, it was underpowered to identify these rare complications. This is partially due to the unusual need for general anesthesia in low-risk patients, as noted earlier. Data on the total number of women who underwent general anesthesia in the current review were limited, as not every study within the meta-analysis included this information.

CHALLENGES TO IMPLEMENTATION

Stemming the cultural tide

One challenge to implementation is changing the culture of practice regarding low-risk pregnant women in labor, as well as the opinions of other health care providers and hospital policies that oppose less restrictive oral intake during labor.

ACKNOWLEDGEMENT

The PURLs Surveillance System was supported in part by Grant Number UL1RR024999 from the National Center For Research Resources, a Clinical Translational Science Award to the University of Chicago. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Research Resources or the National Institutes of Health.

References

1. Ciardulli A, Saccone G, Anastasio H, et al. Less-restrictive food intake during labor in low-risk singleton pregnancies: a systematic review and meta-analysis. Obstet Gynecol. 2017;129:473-480.

2. Mendelson CL. The aspiration of stomach contents into the lungs during obstetric anesthesia. Am J Obstet Gynecol. 1946;52:191-205.

3. Chackowicz A, Spence AR, Abenhaim HA. Restrictions on oral and parenteral intake for low-risk labouring women in hospitals across Canada: a cross-sectional study. J Obstet Gynaecol Can. 2016;38:1009-1014.

4. Warner MA, Warner ME, Weber JG. Clinical significance of pulmonary aspiration during perioperative period. Anesthesiology. 1993;78:56-62.

5. Robinson M, Davidson A. Aspiration under anaesthesia: risk assessment and decision-making. Cont Educ Anaesth Crit Care Pain. 2014;14:171-175.

6. Committee on Obstetric Practice. ACOG Committee Opinion No. 441. Oral intake during labor. Obstet Gynecol. 2009;114:714. Reaffirmed 2017.

7. Singata M, Tranmer J, Gyte GM. Restricting oral fluid and food intake during labour. Cochrane Database Syst Rev. 2013;(8):CD003930.

References

1. Ciardulli A, Saccone G, Anastasio H, et al. Less-restrictive food intake during labor in low-risk singleton pregnancies: a systematic review and meta-analysis. Obstet Gynecol. 2017;129:473-480.

2. Mendelson CL. The aspiration of stomach contents into the lungs during obstetric anesthesia. Am J Obstet Gynecol. 1946;52:191-205.

3. Chackowicz A, Spence AR, Abenhaim HA. Restrictions on oral and parenteral intake for low-risk labouring women in hospitals across Canada: a cross-sectional study. J Obstet Gynaecol Can. 2016;38:1009-1014.

4. Warner MA, Warner ME, Weber JG. Clinical significance of pulmonary aspiration during perioperative period. Anesthesiology. 1993;78:56-62.

5. Robinson M, Davidson A. Aspiration under anaesthesia: risk assessment and decision-making. Cont Educ Anaesth Crit Care Pain. 2014;14:171-175.

6. Committee on Obstetric Practice. ACOG Committee Opinion No. 441. Oral intake during labor. Obstet Gynecol. 2009;114:714. Reaffirmed 2017.

7. Singata M, Tranmer J, Gyte GM. Restricting oral fluid and food intake during labour. Cochrane Database Syst Rev. 2013;(8):CD003930.

Issue
The Journal of Family Practice - 67(6)
Issue
The Journal of Family Practice - 67(6)
Page Number
379-380
Page Number
379-380
Publications
Publications
Topics
Article Type
Display Headline
Let low-risk moms eat during labor?
Display Headline
Let low-risk moms eat during labor?
Sections
PURLs Copyright
Copyright © 2018. The Family Physicians Inquiries Network. All rights reserved.
Inside the Article

PRACTICE CHANGER

Allowing low-risk patients planning for a vaginal delivery less restrictive diets during labor does not seem to increase the risk of aspiration or other harms and may shorten labor.1

STRENGTH OF RECOMMENDATION

A: Based on a meta-analysis of 10 randomized controlled trials (RCTs) in tertiary hospitals.

Ciardulli A, Saccone G, Anastasio H, et al. Less-restrictive food intake during labor in low-risk singleton pregnancies: a systematic review and meta-analysis. Obstet Gynecol. 2017;129:473-480.

Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
PubMed ID
29879238
Disqus Comments
Default
Use ProPublica
Article PDF Media
Media Files

Enlarging nodule under the toenail • no history of trauma • unremarkable medical history • Dx?

Article Type
Changed
Display Headline
Enlarging nodule under the toenail • no history of trauma • unremarkable medical history • Dx?

THE CASE

A 28-year-old woman with an unremarkable medical history presented with an enlarging nodule that had been growing under her left great toenail for 6 months. The patient monitored the nodule, hoping that it would resolve on its own, but found that it steadily increased in size and began to displace the nail, causing pain. At the time of presentation, the nodule measured approximately 10 mm in diameter, and there was significant (~80°) superior displacement of the nail (FIGURE 1).

Enlarging nodule under toenail

An initial radiograph identified a 5.5-mm bony density arising from the dorsal surface of the left first distal phalanx with no significant degenerative changes (FIGURE 2). A subsequent magnetic resonance image confirmed the bony excrescence and noted marrow continuity. A thin amount of T2 bright signal was also observed, suggesting either a cartilaginous cap or soft tissue edema secondary to pressure on the nail bed (FIGURE 3).

Initial radiograph

THE DIAGNOSIS

Histologic examination demonstrated a thin (3 mm) cartilaginous cap overlying an area of mature fibrocartilage with no definite periosteum. The osseous component appeared to mature from the cartilage, and the marrow was focally fatty and fibrosed (FIGURES 4A and 4B). Expert consultation with the Joint Pathology Center confirmed a benign osteochondromatous lesion.

Additional findings on MRI

The histologic differential diagnosis of this patient’s lesion included subungual exostosis and osteochondroma. Based on the patient’s age, location of the lesion, and histologic findings, the final diagnosis was subungual exostosis.

Histologic findings

DISCUSSION

Subungual exostoses are benign osteocartilaginous tumors that most commonly affect children and young adults. They predominantly manifest on the dorsomedial aspect of the tip of the great toe (~80%), but can occur on other digits of the foot or hand.1 They are caused by a proliferation of fibrous tissue under the nail bed. The fibrocartilage cap then undergoes endochondral ossification to woven bone and lamellar bone trabeculae. As these lesions mature, they establish continuity with the underlying bone in the phalanx.2 Subungual exostoses were once thought to represent a proliferative response to trauma, but further research has identified a recurrent t(X;6) (q22;q13-14) translocation, suggesting a neoplastic origin.3

 

Osteochondromas are also common benign tumors formed by endochondral ossification, although secondary transformation into low-grade chondrosarcomas is well-documented.1 Osteochondromas commonly affect younger patients. They occur at epiphyseal areas of developing bone and have a hyaline matrix and chondrocyte pattern similar to that of a normal epiphyseal area, with confluence to the underlying trabecular and cortical bone. They are not caused by previous trauma and generally only become symptomatic after they have grown large enough to cause mechanical problems.1

Continue to: More diagnoses to consider

 

 

More diagnoses to consider

Other potential diagnoses for benign osteochondromatous lesions include bizarre parosteal osteochondromatous proliferations (BPOP) and digital mucous cysts.

Osteocartilaginous tumors present as rapidly growing lesions on the distal tips of fingers and toes, but may also occur on long bones and on the skull.

BPOPs, also known as Nora’s lesions (crediting preliminary research performed by Nora and colleagues in 19834), are irregular formations of hypercellular cartilage, bone, and large chondrocytes. They predominantly occur in the small bones of the hands and feet, but may involve the skull and long bones.3 Unlike subungual exostoses and osteochondromas, BPOPs tend to occur in the third and fourth decades of life and generally do not alter, or have continuity with, the underlying bone.4

Histologically, BPOPs undergo irregular maturation, leaving a characteristic blue tint at the border of the newly formed trabecular bone. As with subungual exostoses, these lesions were traditionally believed to be reactive in nature. However, cytogenetic studies have identified variant translocations involving 1q32 (most commonly t[1;17] [q32;q21]) that are unique and common to these lesions.5

Digital mucous cysts are benign ganglion cysts that typically appear in the distal interphalangeal joints or at the proximal nail fold. They are believed to result from mucoid degeneration of connective tissue. Although generally associated with the hands, these cysts can also occur on the feet.6

Continue to: Our patient's outcome

 

 

Our patient’s outcome

After orthopedic consultation, the lesion and a 5 × 5-mm portion of the adherent germinal nail matrix were resected operatively through a medial excision. A small flap of the lateral nail matrix was rotated to cover the matrix defect, and the wound was closed. Postoperatively, the patient experienced slow wound healing (a total of 3 weeks), but there was no recurrence of the lesion at the 2-month follow-up.

THE TAKEAWAY

Osteocartilaginous tumors present as rapidly growing lesions on the distal tips of fingers and toes, but they may also occur on long bones and on the skull. Rarely malignant in nature, most of these lesions can be differentiated by location, histopathologic features, and patient age at onset. Consider surgical consultation and excision for relief of pain and/or cosmetic reasons. Recurrence is rare.

CORRESPONDENCE
Michael Barna, MD, Naval Hospital Camp Lejeune, Department of Family Medicine, 100 Brewster Blvd, Camp Lejeune, NC 28547; [email protected].

References

1. Miller-Breslow A, Dorfman HD. Dupuytren’s (subungual) exostosis. Am J Surg Pathol. 1988;12:368-378.

2. DaCambra MP, Gupta SK, Ferri-de-Barros F. Subungual exostosis of the toes: a systematic review. Clin Orthop Relat Res. 2014;472:1251-1259.

3. Meneses MF, Unni KK, Swee RG. Bizarre parosteal osteochondromatous proliferation of bone (Nora’s lesion). Am J Surg Pathol. 1993;17:691-697.

4. Nora FE, Dahlin DC, Beabout JW. Bizarre parosteal osteochondromatous proliferations of the hand and feet. Am J Surg Pathol. 1983;7:245-250.

5. Zambrano E, Nosé V, Perez-Atayde AR, et al. Distinct chromosomal rearrangements in subungual (Dupuytren) exostosis and bizarre parosteal osteochondromatous proliferation (Nora lesion). Am J Surg Pathol. 2004;28:1033-1039.

6. Salerni G, Alonso C. Images in clinical medicine. Digital mucous cyst. N Engl J Med. 2012;366:1335.

Article PDF
Author and Disclosure Information

Department of Family Medicine (Drs. Barna and Masuda), Department of Pathology (Dr. Peterson), and Department of Orthopedic Surgery (Dr. Skeehan), US Naval Hospital Yokosuka, Japan
[email protected]

The authors reported no potential conflict of interest relevant to this article.

The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, or the US Government.

Issue
The Journal of Family Practice - 67(6)
Publications
Topics
Page Number
374-375,377
Sections
Author and Disclosure Information

Department of Family Medicine (Drs. Barna and Masuda), Department of Pathology (Dr. Peterson), and Department of Orthopedic Surgery (Dr. Skeehan), US Naval Hospital Yokosuka, Japan
[email protected]

The authors reported no potential conflict of interest relevant to this article.

The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, or the US Government.

Author and Disclosure Information

Department of Family Medicine (Drs. Barna and Masuda), Department of Pathology (Dr. Peterson), and Department of Orthopedic Surgery (Dr. Skeehan), US Naval Hospital Yokosuka, Japan
[email protected]

The authors reported no potential conflict of interest relevant to this article.

The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, or the US Government.

Article PDF
Article PDF

THE CASE

A 28-year-old woman with an unremarkable medical history presented with an enlarging nodule that had been growing under her left great toenail for 6 months. The patient monitored the nodule, hoping that it would resolve on its own, but found that it steadily increased in size and began to displace the nail, causing pain. At the time of presentation, the nodule measured approximately 10 mm in diameter, and there was significant (~80°) superior displacement of the nail (FIGURE 1).

Enlarging nodule under toenail

An initial radiograph identified a 5.5-mm bony density arising from the dorsal surface of the left first distal phalanx with no significant degenerative changes (FIGURE 2). A subsequent magnetic resonance image confirmed the bony excrescence and noted marrow continuity. A thin amount of T2 bright signal was also observed, suggesting either a cartilaginous cap or soft tissue edema secondary to pressure on the nail bed (FIGURE 3).

Initial radiograph

THE DIAGNOSIS

Histologic examination demonstrated a thin (3 mm) cartilaginous cap overlying an area of mature fibrocartilage with no definite periosteum. The osseous component appeared to mature from the cartilage, and the marrow was focally fatty and fibrosed (FIGURES 4A and 4B). Expert consultation with the Joint Pathology Center confirmed a benign osteochondromatous lesion.

Additional findings on MRI

The histologic differential diagnosis of this patient’s lesion included subungual exostosis and osteochondroma. Based on the patient’s age, location of the lesion, and histologic findings, the final diagnosis was subungual exostosis.

Histologic findings

DISCUSSION

Subungual exostoses are benign osteocartilaginous tumors that most commonly affect children and young adults. They predominantly manifest on the dorsomedial aspect of the tip of the great toe (~80%), but can occur on other digits of the foot or hand.1 They are caused by a proliferation of fibrous tissue under the nail bed. The fibrocartilage cap then undergoes endochondral ossification to woven bone and lamellar bone trabeculae. As these lesions mature, they establish continuity with the underlying bone in the phalanx.2 Subungual exostoses were once thought to represent a proliferative response to trauma, but further research has identified a recurrent t(X;6) (q22;q13-14) translocation, suggesting a neoplastic origin.3

 

Osteochondromas are also common benign tumors formed by endochondral ossification, although secondary transformation into low-grade chondrosarcomas is well-documented.1 Osteochondromas commonly affect younger patients. They occur at epiphyseal areas of developing bone and have a hyaline matrix and chondrocyte pattern similar to that of a normal epiphyseal area, with confluence to the underlying trabecular and cortical bone. They are not caused by previous trauma and generally only become symptomatic after they have grown large enough to cause mechanical problems.1

Continue to: More diagnoses to consider

 

 

More diagnoses to consider

Other potential diagnoses for benign osteochondromatous lesions include bizarre parosteal osteochondromatous proliferations (BPOP) and digital mucous cysts.

Osteocartilaginous tumors present as rapidly growing lesions on the distal tips of fingers and toes, but may also occur on long bones and on the skull.

BPOPs, also known as Nora’s lesions (crediting preliminary research performed by Nora and colleagues in 19834), are irregular formations of hypercellular cartilage, bone, and large chondrocytes. They predominantly occur in the small bones of the hands and feet, but may involve the skull and long bones.3 Unlike subungual exostoses and osteochondromas, BPOPs tend to occur in the third and fourth decades of life and generally do not alter, or have continuity with, the underlying bone.4

Histologically, BPOPs undergo irregular maturation, leaving a characteristic blue tint at the border of the newly formed trabecular bone. As with subungual exostoses, these lesions were traditionally believed to be reactive in nature. However, cytogenetic studies have identified variant translocations involving 1q32 (most commonly t[1;17] [q32;q21]) that are unique and common to these lesions.5

Digital mucous cysts are benign ganglion cysts that typically appear in the distal interphalangeal joints or at the proximal nail fold. They are believed to result from mucoid degeneration of connective tissue. Although generally associated with the hands, these cysts can also occur on the feet.6

Continue to: Our patient's outcome

 

 

Our patient’s outcome

After orthopedic consultation, the lesion and a 5 × 5-mm portion of the adherent germinal nail matrix were resected operatively through a medial excision. A small flap of the lateral nail matrix was rotated to cover the matrix defect, and the wound was closed. Postoperatively, the patient experienced slow wound healing (a total of 3 weeks), but there was no recurrence of the lesion at the 2-month follow-up.

THE TAKEAWAY

Osteocartilaginous tumors present as rapidly growing lesions on the distal tips of fingers and toes, but they may also occur on long bones and on the skull. Rarely malignant in nature, most of these lesions can be differentiated by location, histopathologic features, and patient age at onset. Consider surgical consultation and excision for relief of pain and/or cosmetic reasons. Recurrence is rare.

CORRESPONDENCE
Michael Barna, MD, Naval Hospital Camp Lejeune, Department of Family Medicine, 100 Brewster Blvd, Camp Lejeune, NC 28547; [email protected].

THE CASE

A 28-year-old woman with an unremarkable medical history presented with an enlarging nodule that had been growing under her left great toenail for 6 months. The patient monitored the nodule, hoping that it would resolve on its own, but found that it steadily increased in size and began to displace the nail, causing pain. At the time of presentation, the nodule measured approximately 10 mm in diameter, and there was significant (~80°) superior displacement of the nail (FIGURE 1).

Enlarging nodule under toenail

An initial radiograph identified a 5.5-mm bony density arising from the dorsal surface of the left first distal phalanx with no significant degenerative changes (FIGURE 2). A subsequent magnetic resonance image confirmed the bony excrescence and noted marrow continuity. A thin amount of T2 bright signal was also observed, suggesting either a cartilaginous cap or soft tissue edema secondary to pressure on the nail bed (FIGURE 3).

Initial radiograph

THE DIAGNOSIS

Histologic examination demonstrated a thin (3 mm) cartilaginous cap overlying an area of mature fibrocartilage with no definite periosteum. The osseous component appeared to mature from the cartilage, and the marrow was focally fatty and fibrosed (FIGURES 4A and 4B). Expert consultation with the Joint Pathology Center confirmed a benign osteochondromatous lesion.

Additional findings on MRI

The histologic differential diagnosis of this patient’s lesion included subungual exostosis and osteochondroma. Based on the patient’s age, location of the lesion, and histologic findings, the final diagnosis was subungual exostosis.

Histologic findings

DISCUSSION

Subungual exostoses are benign osteocartilaginous tumors that most commonly affect children and young adults. They predominantly manifest on the dorsomedial aspect of the tip of the great toe (~80%), but can occur on other digits of the foot or hand.1 They are caused by a proliferation of fibrous tissue under the nail bed. The fibrocartilage cap then undergoes endochondral ossification to woven bone and lamellar bone trabeculae. As these lesions mature, they establish continuity with the underlying bone in the phalanx.2 Subungual exostoses were once thought to represent a proliferative response to trauma, but further research has identified a recurrent t(X;6) (q22;q13-14) translocation, suggesting a neoplastic origin.3

 

Osteochondromas are also common benign tumors formed by endochondral ossification, although secondary transformation into low-grade chondrosarcomas is well-documented.1 Osteochondromas commonly affect younger patients. They occur at epiphyseal areas of developing bone and have a hyaline matrix and chondrocyte pattern similar to that of a normal epiphyseal area, with confluence to the underlying trabecular and cortical bone. They are not caused by previous trauma and generally only become symptomatic after they have grown large enough to cause mechanical problems.1

Continue to: More diagnoses to consider

 

 

More diagnoses to consider

Other potential diagnoses for benign osteochondromatous lesions include bizarre parosteal osteochondromatous proliferations (BPOP) and digital mucous cysts.

Osteocartilaginous tumors present as rapidly growing lesions on the distal tips of fingers and toes, but may also occur on long bones and on the skull.

BPOPs, also known as Nora’s lesions (crediting preliminary research performed by Nora and colleagues in 19834), are irregular formations of hypercellular cartilage, bone, and large chondrocytes. They predominantly occur in the small bones of the hands and feet, but may involve the skull and long bones.3 Unlike subungual exostoses and osteochondromas, BPOPs tend to occur in the third and fourth decades of life and generally do not alter, or have continuity with, the underlying bone.4

Histologically, BPOPs undergo irregular maturation, leaving a characteristic blue tint at the border of the newly formed trabecular bone. As with subungual exostoses, these lesions were traditionally believed to be reactive in nature. However, cytogenetic studies have identified variant translocations involving 1q32 (most commonly t[1;17] [q32;q21]) that are unique and common to these lesions.5

Digital mucous cysts are benign ganglion cysts that typically appear in the distal interphalangeal joints or at the proximal nail fold. They are believed to result from mucoid degeneration of connective tissue. Although generally associated with the hands, these cysts can also occur on the feet.6

Continue to: Our patient's outcome

 

 

Our patient’s outcome

After orthopedic consultation, the lesion and a 5 × 5-mm portion of the adherent germinal nail matrix were resected operatively through a medial excision. A small flap of the lateral nail matrix was rotated to cover the matrix defect, and the wound was closed. Postoperatively, the patient experienced slow wound healing (a total of 3 weeks), but there was no recurrence of the lesion at the 2-month follow-up.

THE TAKEAWAY

Osteocartilaginous tumors present as rapidly growing lesions on the distal tips of fingers and toes, but they may also occur on long bones and on the skull. Rarely malignant in nature, most of these lesions can be differentiated by location, histopathologic features, and patient age at onset. Consider surgical consultation and excision for relief of pain and/or cosmetic reasons. Recurrence is rare.

CORRESPONDENCE
Michael Barna, MD, Naval Hospital Camp Lejeune, Department of Family Medicine, 100 Brewster Blvd, Camp Lejeune, NC 28547; [email protected].

References

1. Miller-Breslow A, Dorfman HD. Dupuytren’s (subungual) exostosis. Am J Surg Pathol. 1988;12:368-378.

2. DaCambra MP, Gupta SK, Ferri-de-Barros F. Subungual exostosis of the toes: a systematic review. Clin Orthop Relat Res. 2014;472:1251-1259.

3. Meneses MF, Unni KK, Swee RG. Bizarre parosteal osteochondromatous proliferation of bone (Nora’s lesion). Am J Surg Pathol. 1993;17:691-697.

4. Nora FE, Dahlin DC, Beabout JW. Bizarre parosteal osteochondromatous proliferations of the hand and feet. Am J Surg Pathol. 1983;7:245-250.

5. Zambrano E, Nosé V, Perez-Atayde AR, et al. Distinct chromosomal rearrangements in subungual (Dupuytren) exostosis and bizarre parosteal osteochondromatous proliferation (Nora lesion). Am J Surg Pathol. 2004;28:1033-1039.

6. Salerni G, Alonso C. Images in clinical medicine. Digital mucous cyst. N Engl J Med. 2012;366:1335.

References

1. Miller-Breslow A, Dorfman HD. Dupuytren’s (subungual) exostosis. Am J Surg Pathol. 1988;12:368-378.

2. DaCambra MP, Gupta SK, Ferri-de-Barros F. Subungual exostosis of the toes: a systematic review. Clin Orthop Relat Res. 2014;472:1251-1259.

3. Meneses MF, Unni KK, Swee RG. Bizarre parosteal osteochondromatous proliferation of bone (Nora’s lesion). Am J Surg Pathol. 1993;17:691-697.

4. Nora FE, Dahlin DC, Beabout JW. Bizarre parosteal osteochondromatous proliferations of the hand and feet. Am J Surg Pathol. 1983;7:245-250.

5. Zambrano E, Nosé V, Perez-Atayde AR, et al. Distinct chromosomal rearrangements in subungual (Dupuytren) exostosis and bizarre parosteal osteochondromatous proliferation (Nora lesion). Am J Surg Pathol. 2004;28:1033-1039.

6. Salerni G, Alonso C. Images in clinical medicine. Digital mucous cyst. N Engl J Med. 2012;366:1335.

Issue
The Journal of Family Practice - 67(6)
Issue
The Journal of Family Practice - 67(6)
Page Number
374-375,377
Page Number
374-375,377
Publications
Publications
Topics
Article Type
Display Headline
Enlarging nodule under the toenail • no history of trauma • unremarkable medical history • Dx?
Display Headline
Enlarging nodule under the toenail • no history of trauma • unremarkable medical history • Dx?
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
PubMed ID
29879237
Disqus Comments
Default
Use ProPublica
Article PDF Media